Podcasts about uc berkeley

Democrats are pushing back on an executive order to end collective bargaining rights for federal workers. Water rescues are underway in Kansas City, MO after a month's worth of rain fell in just 12 hours. Suspects have been charged in the murder of a UC Berkeley professor. Americans are still opening their wallets despite President Donald Trump's tariffs. Plus, a 60s pop star who found recent TikTok fame has died.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Jenny: Ability to make complex financial and legal concepts accessible.Creating a thriving community takes more than goodwill—it requires vision, leadership, and resources. Jenny Kassan, CEO of Opportunity Main Street, is proving that crowdfunding can be a powerful tool for revitalizing communities while offering investors a meaningful way to make a difference.Jenny is raising capital through a regulation crowdfunding campaign on SmallChange to renovate a historic building in Baltimore. This project, called Community Commons, will serve as both a hub for local businesses and a space for community-building activities. The first floor will feature a gathering space, coffee shop, and retail area, while the upper floors will house luxury furnished apartments for short-term rentals.Jenny explains her motivation: “I've believed for a while that it's really important to create a place-based ecosystem to grow this movement to move community capital into small business.” She has already raised $2.5 million for the project but is turning to crowdfunding to close the final gap.What makes this project stand out is its intentional focus on Baltimore. After hosting a women entrepreneurs' event in the city, Jenny fell in love with its historic charm and resilient spirit. “Baltimore is a beautiful, scrappy city,” she says. “There's a renaissance going on… it's a place where you can make a significant impact.”Jenny's choice of SmallChange as the crowdfunding platform is no accident. She highlights the portal's commitment to impact-focused real estate projects and its owner, Eve Picker: “She really cares about her clients… and the design of the page is absolutely beautiful.”By combining real estate with a community-driven mission, Jenny's project offers an opportunity for investors to see both financial returns and social impact. The short-term rental apartments are projected to generate strong revenue, while the first-floor activities will foster relationships, support local businesses, and teach community members how to invest locally.This isn't just about one building. Jenny hopes the Community Commons project will become a replicable model for other cities. “It's about creating a replicable model for community wealth building and supporting the local investing movement,” she says.With projects like these, Jenny is showing how crowdfunding can be a bridge between financial goals and community revitalization.Creating a thriving community takes more than goodwill—it requires vision, leadership, and resources. Jenny Kassan, CEO of Opportunity Main Street, is proving that crowdfunding can be a powerful tool for revitalizing communities while offering investors a meaningful way to make a difference.Jenny is raising capital through a regulation crowdfunding campaign on SmallChange to renovate a historic building in Baltimore. This project, called Community Commons, will serve as both a hub for local businesses and a space for community-building activities. The first floor will feature a gathering space, coffee shop, and retail area, while the upper floors will house luxury furnished apartments for short-term rentals.Jenny explains her motivation: “I've believed for a while that it's really important to create a place-based ecosystem to grow this movement to move community capital into small business.” She has already raised $2.5 million for the project but is turning to crowdfunding to close the final gap.What makes this project stand out is its intentional focus on Baltimore. After hosting a women entrepreneurs' event in the city, Jenny fell in love with its historic charm and resilient spirit. “Baltimore is a beautiful, scrappy city,” she says. “There's a renaissance going on… it's a place where you can make a significant impact.”Jenny's choice of SmallChange as the crowdfunding platform is no accident. She highlights the portal's commitment to impact-focused real estate projects and its owner, Eve Picker: “She really cares about her clients… and the design of the page is absolutely beautiful.”By combining real estate with a community-driven mission, Jenny's project offers an opportunity for investors to see both financial returns and social impact. The short-term rental apartments are projected to generate strong revenue, while the first-floor activities will foster relationships, support local businesses, and teach community members how to invest locally.This isn't just about one building. Jenny hopes the Community Commons project will become a replicable model for other cities. “It's about creating a replicable model for community wealth building and supporting the local investing movement,” she says.With projects like these, Jenny is showing how crowdfunding can be a bridge between financial goals and community revitalization.tl;dr:Jenny Kassan shares her vision for revitalizing Baltimore with a historic real estate project.Community Commons will combine short-term rentals with a hub for local businesses and activities.Jenny highlights the impact of crowdfunding and her partnership with the SmallChange platform.She demonstrates how simplifying financial concepts empowers underserved communities to raise capital.Jenny's replicable model aims to inspire more community wealth-building projects nationwide.How to Develop Simplifying Complex Financial Concepts As a SuperpowerJenny describes her superpower as the ability to make complex financial and legal concepts accessible. She explains, “I've learned so much about finance, securities law… and I feel like my superpower is bringing it down to a level of clarity for people.” Her passion stems from a desire to make the world of finance less opaque and intimidating, especially for those who lack traditional financial knowledge or access to resources.Illustrative Story:Jenny's superpower shone when she helped a worker co-op in Boston called CERO raise capital for a composting business. Comprised of highly disadvantaged individuals, the co-op needed funding for a truck but wanted to retain worker control. Jenny structured an offering of non-voting equity, allowing the workers to remain in charge while raising several hundred thousand dollars. This project exemplifies her ability to simplify financial tools for underserved communities, empowering them to achieve their goals.Actionable Tips to Develop the Superpower:Deepen Your Expertise: Invest time in learning the intricacies of your field, as Jenny did with finance.Practice Simplifying Concepts: Break down complex ideas into clear, relatable language to help others understand them.Empathize with Your Audience: Tailor your explanations to the needs and backgrounds of those you're helping.Stay Mission-Driven: Focus on using your knowledge to empower others and create meaningful change.By following Jenny's example and advice, you can make simplifying complex concepts a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileJenny Kassan (she/her):CEO, Opportunity Main StreetAbout Opportunity Main Street: Opportunity Main Street is growing a place-based community wealth building ecosystem in Baltimore that includes community investing in local business, a community business school, and mutual aid through a time-banking network.Website: opportunitymainstreet.comBiographical Information: Jenny is an attorney, coach, and ecosystem builder focused on capital access for underrepresented entrepreneurs.Jenny earned her J.D. from Yale Law School and a masters degree in City and Regional Planning from UC Berkeley.She is the author of Raise Capital on Your Own Terms: How to Fund Your Business without Selling Your Soul.Jenny co-founded the Sustainable Economies Law Center, the Force for Good Fund, and Opportunity Main Street. X/Twitter Handle: @jennykassan Personal Facebook Profile: facebook.com/jenny.kassanLinkedin: linkedin.com/in/jennykassanInstagram Handle: @thekassangroupSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include FundingHope, DealMaker, DNA, Rancho Affordable Housing (Proactive). Learn more about advertising with us here.Max-Impact MembersThe following Max-Impact Members provide valuable financial support:Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | Lory Moore, Lory Moore Law | Marcia Brinton, High Desert Gear |  Matthew Mead, Hempitecture |  Michael Pratt, Qnetic | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Ralf Mandt, Next Pitch | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.Impact Cherub Club Meeting hosted by The Super Crowd, Inc., a public benefit corporation, on August 19, 2025, at 1:00 PM Eastern. Each month, the Club meets to review new offerings for investment consideration and to conduct due diligence on previously screened deals. To join the Impact Cherub Club, become an Impact Member of the SuperCrowd.SuperCrowdHour, August 20, 2025, at 12:00 PM Eastern. Devin Thorpe, CEO and Founder of The Super Crowd, Inc., will lead a session on "Your Portal, Your Future: How to Choose the Right Reg CF Platform." With so many investment crowdfunding portals available today, selecting the right one can be overwhelming for both founders and investors. In this session, Devin will break down the critical factors to consider—such as platform fees, audience demographics, compliance support, industry focus, and overall user experience. Whether you're a founder planning a raise or an investor exploring where to put your dollars to work, you'll walk away with a clearer understanding of how to evaluate and choose the platform that best aligns with your goals. Don't miss this practical, insight-packed hour designed to help you take your next step in the Reg CF ecosystem with confidence.SuperCrowd25, August 21st and 22nd: This two-day virtual event is an annual tradition but with big upgrades for 2025! We'll be streaming live across the web and on TV via e360tv. Apply for the Live Pitch here. VIPs get access to our better-than-in-person networking, including backstage passes, VIP networking and an exclusive VIP webinar! Get your VIP access for just $25. A select group of affordable sponsorship opportunities is still available. Learn more here.Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Devin Thorpe is featured in a free virtual masterclass series hosted by Irina Portnova titled Break Free, Elevate Your Money Mindset & Call In Overflow, focused on transforming your relationship with money through personal stories and practical insights. June 8-21, 2025.Join Dorian Dickinson, founder & CEO of FundingHope, for Startup.com's monthly crowdfunding workshop, where he'll dive into strategies for successfully raising capital through investment crowdfunding. June 24 at noon Eastern.Future Forward Summit: San Francisco, Wednesday, June 25 · 3:30 - 8:30 pm PDT.Regulated Investment Crowdfunding Summit 2025, Crowdfunding Professional Association, Washington DC, October 21-22, 2025.Impact Accelerator Summit is a live in-person event taking place in Austin, Texas, from October 23–25, 2025. This exclusive gathering brings together 100 heart-centered, conscious entrepreneurs generating $1M+ in revenue with 20–30 family offices and venture funds actively seeking to invest in world-changing businesses. Referred by Michael Dash, participants can expect an inspiring, high-impact experience focused on capital connection, growth, and global impact.Call for community action:Please show your support for a tax credit for investments made via Regulation Crowdfunding, benefiting both the investors and the small businesses that receive the investments. Learn more here.If you would like to submit an event for us to share with the 9,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

Elizabeth Linos is the Emma Bloomberg Associate Professor for Public Policy and Management, and Faculty Director of The People Lab at the Harvard Kennedy School of Government. The majority of her research focuses on how to improve government by focusing on its people and the services they deliver. Specifically, she uses insights from behavioral science and evidence from public management to consider how to recruit, retain, and support the government workforce, how to improve resident-state interactions, and how to better integrate evidence-based policymaking into government. Her research has been published in numerous academic journals including Nature Human Behaviour, Econometrica, The Journal for Public Administration Research and Theory (JPART), The Journal of Political Economy, Public Administration Review, American Economic Journal: Economic Policy, Behavioural Public Policy, and others. Prior to joining the Harvard Kennedy School faculty, Linos has been an assistant professor at UC Berkeley; the VP and Head of Research and Evaluation at the Behavioral Insights Team in North America; and policy advisor to the Greek Prime Minister, George Papandreou, focusing on social innovation and public sector reform. Linos has been named one of the top 10 influencers in local government by ELGL, and was the 2023 recipient of the prestigious David N. Kershaw Award and Prize "established to honor persons who, before the age of 40, have made distinguished contributions to the field of public policy analysis and management."Ralph Ranalli of the HKS Office of Communications and Public Affairs is the host, producer, and editor of HKS PolicyCast. A former journalist, public television producer, and entrepreneur, he holds an BA in political science from UCLA and a master's in journalism from Columbia University.Scheduling and logistical support for PolicyCast has been provided by Lilian Wainaina. Design and graphics support has been provided by Laura King. Web design and social media promotion support has been provided by Catherine Santrock and Natalie Montaner. Editorial support has been provided by Nora Delaney and Robert O'Neill. 

Crystal Haryanto is the author of The Glory of Giving Everything, and in this conversation, we learn how to apply Taylor Swift's business model in our lives and careers. You'll hear how Taylor has been successful singing different genres of music, engaging with her fans, creating outstanding shows that led to her becoming a billionaire from her music and performances. You'll see how Taylor took control of her “reputation” after having rumors spread about her and then controlling the narrative. You, too, can be the star of your life. There is so much to learn from this icon. This is a fun and interesting conversation. Be sure to share it with your Swiftie friends and family. But you don't have to be a fan to learn something from this interview. Crystal works in economic consulting in San Francisco. She graduated with High Honors from UC Berkeley in 2023 with degrees in economics, cognitive science, and public policy. She was a two-time winner of the Cal Alumni Leadership Award. She founded Artistry, Policy, & Entrepreneurship: Taylor's Version, a course that received global media coverage, including a televised broadcast on CBS. RESOURCES MENTIONED JOIN MICHELE'S NEWSLETTER + Receive A Free Curated List of 52 Self-care Tips Michele on IG GUEST INFORMATION Website: https://thegloryofgivingeverything.com/ Book: The Glory of Giving Everything: The Taylor Swift Business Model (affiliate link) This conversation is for educational and entertainment purposes only. It does NOT constitute medical, mental health, legal, business, or other advice. Always consult a qualified and trusted professional before making any decisions. If you enjoyed this interview, please take a moment to rate and review it on Apple Podcasts. Your reviews are so appreciated! XO, Michele

Steamy Saturday at Ambitious Ales! Saturday July 19, 20255:00 PM  9:00 PM (Jake will be there around 8)Ambitious Ales    4019 Atlantic Ave, Long BeachDUMPLINS: CLICK HERE for the BEST dumplings you will EVER eat. https://www.jodisdumplins.com/Enjoy the What's Bruin Show Network!Multiple shows to entertain you on one feed:Support WBS at Patreon.com/WhatsBruinShow for just $2/month and get exclusive content and access to our SLACK channel.Twitter/X: @whatsbruinshow        Instagram: @whatsbruinshowCall the What's Bruin Network Hotline at 805-399-4WBS (Suck it Reign of Troy)We are also on YouTube HEREGet Your WBSN MERCH - Go to our MyLocker Site by Clicking HEREWhat's Bruin Show- A conversation about all things Bruin over drinks with Bruin Report Online's @mikeregaladoLA, @wbjake68 and friends!Subscribe to the What's Bruin Show at whatsbruin.substack.comEmail us at: whatsbruinshow@gmail.comTweet us at: @whatsbruinshowWest Coast Bias - LA Sports (mostly Lakers, Dodgers and NFL) with Jamaal and JakeSubscribe to West Coast Bias at wbwestcoastbias.substack.comEmail us at: WB.westcoastbias@gmail.comTweet us at: @WBwestcoastbiasThe BEAR Minimum - Jake and his Daughter Megan talk about student life and Cal Sports during her first year attending UC Berkeley.Subscribe to The BEAR Minimum at thebearminimum.substack.comEmail us at: wb.bearminimum@gmail.comTweet us at: @WB_BearMinimumPlease rate and review us on whatever platform you listen on.e=true

Sam speaks to CEO and co-founder of Split Atom Labs, Aaron Vernon, whose game studio is the developer of accessible mobile game Land of Livia, currently available on all Apple devices for gamers who are blind or have low vision. We also feature part three of Sam's interview with Ian Bailey, covering his time between teaching and research positions at University of Melbourne and UC Berkeley.Support this Vision Australia Radio program: https://www.visionaustralia.org/donate?src=radio&type=0&_ga=2.182040610.46191917.1644183916-1718358749.1627963141See omnystudio.com/listener for privacy information.

The United States and Indonesia have reached a trade agreement, President Donald Trump announced on social media. “Great deal, for everybody, just made with Indonesia. I dealt directly with their highly respected President,” Trump said in a post on Truth Social. This comes soon after the president sent a formal letter to Indonesia announcing a 32 percent levy on Indonesian goods entering the United States, effective Aug. 1.The Chinese communist party continues to tighten control over critical mineral supply chains. The House Foreign Affairs East Asia & the Pacific Subcommittee held a hearing on Tuesday to strategize ways to break the choke-hold.Presidents from Georgetown University, UC Berkeley, and the City University of New York testified on Tuesday before the House Education and Workforce Committee on the topic of anti-Semitism in higher education. Lawmakers examined the role of faculty, funding, and ideology in the growth of anti-Semitism on college campuses.

Go behind the scenes of The Sphere in Las Vegas as Phil Cooke https://philcooke.com interviews Head of Physical Production, Ralph Winter. Proven to be one of Hollywood's most profitable assets with blockbusters including X-MEN, PLANET OF THE APES, and WOLVERINE, Ralph takes us inside the production process of The Sphere's cinematic experience, including award-winning director Darren Aronofsky's “Postcard from Earth” produced for the Las Vegas venue. Includes inside information on filming with the Big Sky Camera featuring a 165-degree wide field of view, produced for the world's largest high-definition LED screen with 164,000 speakers in the building. Filmmakers will appreciate the storytelling process in this unique medium and the career advice from this seasoned Hollywood producer!

The Uninsurable Future: How Climate-Driven Insurance Risk is Reshaping Real Estate   The Canary in the CRE Coal Mine If insurance is the canary in the coal mine for climate risk, then the bird has stopped singing. That's the warning from Dave Jones, former California Insurance Commissioner and current Director of the Climate Risk Initiative at UC Berkeley. In a conversation that touches on reinsurance markets, mortgage delinquencies, lender behavior, and regulatory dysfunction, Jones laid out the most sobering climate-related CRE risk analysis to date: we are already living through a systemic insurance crisis—and commercial real estate is not exempt.   “We are marching steadily towards an uninsurable areas in this country,” Jones warns.   From Homeowners to High-Rises: What the Data Shows Much of the early distress has been observed in the residential and small business markets, where data is more publicly available. A study by the Dallas Fed, cited by Jones, found a direct correlation between areas hardest hit by climate events and surging insurance premiums, non-renewals, and mortgage delinquencies.   But commercial real estate isn't insulated. While pricing data is less transparent due to looser filing requirements, Jones states, “everything that I've seen indicates that those [commercial] rates are going up too,” particularly in regions where catastrophic climate events are becoming more frequent and severe.   Take Florida. One of our clients' office tower's premiums jumped from $300,000 to $1.2 million in a single renewal cycle. That's straight off the bottom line. The hit is entirely non-accretive; it's pure cost.   The Feedback Loop: Insurance, Lending, and Liquidity As insurance availability shrinks and prices soar, lending dries up. Lenders want to see that there is property and casualty insurance yet, as it becomes harder to get, that has implications in credit markets… and flow-through implications to the real economy.   It's not just anecdotal. Jones references studies showing that banks are offloading loans insured by lower-rated, higher-risk insurers to Fannie Mae and Freddie Mac, effectively shifting the risk onto taxpayers. That means if a hurricane hits and the house is knocked down, there isn't insurance available, potentially because the insurance company went insolvent.   The trend is clear: insurance stress is bleeding into credit markets and weakening the foundations of the entire real estate financing stack.   The “Deregulation” Illusion Some states, like Florida, are trying to respond by loosening regulatory constraints to attract insurers. Jones is skeptical. “Florida rates are four times the national average,” he says. The state has adopted taxpayer-funded reinsurance schemes, weakened litigation protections, and allowed less-robust rating agencies to operate.   Still, “the national branded home insurers are not writing in Florida… they can't make a profit,” says Jones. “So even with all these changes, the background risk is too great.”   In short: deregulation cannot solve a fundamentally unprofitable underwriting environment driven by climate volatility.   Adaptation Isn't Being Priced In - Yet Jones is more optimistic about resilience measures. Home hardening, defensible space, and forest management, especially in wildfire-prone states like California, can materially reduce losses. Commercial insurers often have engineering staff to assess and recommend these strategies.   But the industry hasn't kept pace. “Insurers, by and large, are not accounting for property, community, and landscape-scale adaptation and resilience in their models,” Jones says. One exception is Colorado, which passed a law requiring insurers to factor in proven risk mitigation. This could prove to be a model for commercial markets, but it's early and insurers remain price takers in the face of mounting losses.   From Reinsurance to Municipal Bonds: Signals to Watch What market signals should CRE investors monitor? Jones suggests: Insurance pricing and non-renewals: leading indicators of distress. Reinsurance costs: though recently softening, they've trended upward for years. Lender behavior: especially offloading risky loans to agencies. Rating agency downgrades: particularly for municipalities facing severe climate risk. Housing market mispricing: First Street Foundation estimates as much as $1 trillion in residential overvaluation due to underpriced climate risk. Any of these could tip the balance in specific markets or signal a broader inflection point.   A Slow Collapse or a Sudden Shock? Is this a long-term crisis or a fast-moving one? “It's happening in real time now,” says Jones. “It's more likely that this will be a steady glide into uninsurability… as opposed to one catastrophic event that brings the whole house of cards down.”   Still, the metaphor is chilling. The systemic risks posed by climate-driven insurance failure are already manifesting across sectors. Whether the collapse is gradual or sudden, the endpoint is clear.   “There is no place in the United States where you have a ‘get out of climate change free' card,” Jones warns.   For CRE professionals, that means a hard reckoning is ahead – not just with climate, but with underwriting, capital access, and portfolio risk in a fundamentally altered landscape.   *** In this series, I cut through the noise to examine how shifting macroeconomic forces and rising geopolitical risk are reshaping real estate investing.   With insights from economists, academics, and seasoned professionals, this show helps investors respond to market uncertainty with clarity, discipline, and a focus on downside protection.    Subscribe to my free newsletter for timely updates, insights, and tools to help you navigate today's volatile real estate landscape. You'll get: Straight talk on what happens when confidence meets correction - no hype, no spin, no fluff. Real implications of macro trends for investors and sponsors with actionable guidance. Insights from real estate professionals who've been through it all before. Visit GowerCrowd.com/subscribe Email: adam@gowercrowd.com Call: 213-761-1000

Comprehensive coverage of the day's news with a focus on war and peace; social, environmental and economic justice. Clock ticking for Trump bill clawing back funds for foreign aid and public media; House hearing on campus antisemitism targets UC Berkeley, Dem Ilhan Omar compares hearing to McCarthy witch-hunts; UN reports child nutrition in Gaza doubled under Israeli restrictions; UN says civilians in Ukraine coming under fire in record numbers as Russian strikes surge; Tariff-driven inflation begins to show in rising costs for furniture, clothing, large appliances The post Deadline looms for bill clawing back funds for foreign aid and public media; UC Berkeley chancellor defends free speech at House antisemitism hearing – July 15, 2025 appeared first on KPFA.

What if we could have all the immune-boosting benefits of raw milk without any of the safety risks? That's the promise of today's episode.Bob Comstock is the CEO of Tamarack Biotics and inventor of a revolutionary UV pasteurization technology that just received FDA approval after 12 years of development. Unlike traditional heat pasteurization that destroys up to 70% of milk's beneficial compounds, Bob's "cold pasteurization" process preserves 93-100% of bioactive proteins while eliminating dangerous pathogens.European studies have consistently shown that children who consume raw milk are protected from developing asthma, hay fever, eczema, and food allergies – conditions that now affect nearly half of all children. But the scientific community has confirmed that heating milk destroys this protective effect. Bob's UV technology could be the key to making these health benefits safely accessible to everyone.Bob shares the fascinating origin story of how he discovered this technology while living in Singapore, the hundreds of pathogens they had to test against for FDA approval, and why a regulation from the 1970s nearly derailed the entire project. He also discusses their clinical trials showing elderly participants had 120% more antibodies after consuming UV-treated milk protein compared to traditional whey protein, and their upcoming studies on allergy prevention in children.This technology could revolutionize not just the dairy industry, but potentially help address America's chronic disease epidemic by making truly nutritious milk widely available for the first time in over 150 years.About Bob ComstockBob Comstock is the founder and CEO of Tamarack Biotics, a food‑tech company based in Fresno, California. With a Mechanical Engineering degree from UC Berkeley, Bob launched Tamarack in 2011 to pioneer healthier dairy solutions. Before starting Tamarack Biotics, he started Compass Foods, which developed the world's most water soluble food grade emulsifier. Under his leadership, Tamarack developed TruActive®, the first FDA‑accepted UV‑based milk treatment that kills pathogens while retaining enzymes, proteins, and immune‑boosting bioactives—without traditional pasteurization.Discounts Get 10% off delicious local farm-fresh food delivered to your door with my link for FarmMatch: https://farmmatch.com/jane Get 15% off high-quality Italian olive oil with code FARMTOFUTURE: https://shop.vignolifood.com/FARMTOFUTURE Get 40% the CircleDNA's Premium DNA test with code JANEZHANG: https://circledna.com/premium Connect with Jane Z. Instagram: @farm.to.future Email: jane@farmtofuture.co Website: farmtofuture.co

00:08 — John Feffer is Director of Foreign Policy in Focus. 00:33 — Dr. John Swartzberg, clinical professor emeritus of infectious diseases at UC Berkeley's School of Public Health. The post Russia's War in Ukraine; Plus, Corona Calls appeared first on KPFA.

A new poll reveals that most Californians feel democracy is in danger. KCSB's Kyle Rokes walks us through the numbers.

In a time when Jewish trauma is being weaponized and used to justify the Israeli genocide against Palestinians, the book An Anti-Zionist Path to Embodied Jewish Healing: Somatic Practices to Heal Historical Wounds, Unlearn Oppression, and Create a Liberated World to Come presents a liberatory model for Jewish healing firmly rooted in Jewish spiritual values. In this book based conversation the panel  discusses the intersection of healing and activism that can make our organizing movements more healing and our healing more political to strengthen our collective work for a free Palestine and a Jewishness beyond Zionism. Over the last year and a half, many of us activists and organizers have felt hopeless, despairing, and angry that we have not been able to stop this genocidal violence being carried out in our names. Sometimes we take these feelings out on each other by being overly critical and unkind, which leads to fractures inside our movements. At this time of rising fascism when the Trump administration is exploiting the fractures on the Left to create division, we can incorporate body-based healing to strengthen our collective power that moves us closer to a liberated world and a free Palestine. Wendy Elisheva Somerson (Wes) is a queer non-binary, disabled, cat- loving Ashkenazi Jewish somatic healer, writer, activist, and visual artist residing on Duwamish and Coast Salish land. One of the founders of the Seattle chapter of Jewish Voice for Peace, they have been active in Palestinian solidarity work for more than two decades. As a politicized healer, Wes works at the intersection of personal and collective healing with individuals, groups, and organizations. They are the creator and facilitator of Ruach, an ongoing anti-Zionist, body-based Jewish healing group. Cecilie Surasky is the Director of Communications and Narrative at the Othering & Belonging Institute (OBI) at UC Berkeley, a global research and advocacy organization focused on understanding the structures of exclusion and building a world where all people belong. Cecilie's career spans decades of mobilizing politically marginalized communities, and she's proud of her role in building a co-liberation movement as the founding communications and later deputy director of Jewish Voice for Peace (JVP). She draws from her own family's journey with traumatic grief, belonging and resilience. Penny Rosenwasser, Ph.D., is a lifelong heartfelt rabble-rouser for justice. A queer/lesbian white Jewish intersectional feminist, Penny is author of the award-winning Hope into Practice, Jewish women choosing justice despite our fears. She was a founding Board member and early leader of Jewish Voice for Peace, co-teaches an Antisemitism/Anti-Arabism class with a Palestinian colleague at City College of San Francisco, and serves on the Advisory Council of the Center for Jewish Nonviolence. An educator, public speaker, fundraiser and  facilitator, Penny organized events for the Middle East Children's Alliance for 32 years and is a racial justice leader at Kehilla synagogue.           The post An Anti-Zionist Path to Embodied Jewish Healing: A conversation about the intersection of healing and activism with Wendy Elisheva Somerson (Wes), Cecilie Surasky, and Penny Rosenwaswer appeared first on KPFA.

Can probability theory help explain how the mind works? In this episode of Deep Dives with Iman, host Iman Mossavat talks with Dr. Hadi Vafaii, a postdoctoral scholar at UC Berkeley's Redwood Center for Theoretical Neuroscience, working in Jacob Yates's lab. The conversation focuses on “perception as inference”—a century-old idea that continues to influence modern neuroscience, from predictive coding to the free energy principle. While rooted in probability theory and Bayesian statistics, Hadi builds intuition step by step, using simple, relatable examples. He explains how the brain interprets the world by guessing the hidden causes behind what we see and hear, combining prior knowledge with new evidence. The episode also explores how personal beliefs and life experiences shape interpretation and why uncertainty is a vital part of life rather than a weakness.

Bruce Praet is a well-known name in law enforcement, especially in California. He co-founded a company called Lexipol that contracts with more than 95 percent of police departments in the state and offers its clients trainings and ready-made policies.In one of Praet's online training webinars, he offers a piece of advice that policing experts have called inhumane. It's aimed at protecting officers and their departments from lawsuits.After police kill someone, they are supposed to notify the family. Instead of delivering the news immediately, Praet advises officers to first ask about the person who was killed to get as much unflattering information as possible. Reporter Brian Howey started looking into this advice when he was with the Investigative Reporting Program at UC Berkeley's Graduate School of Journalism. This week on Reveal, he delves into his finding that officers have been using this tactic across California. He also finds that the information families disclosed before they knew their relative was killed later affected their lawsuits against law enforcement departments. This is an update of an episode that originally aired in November 2023. Support Reveal's journalism at Revealnews.org/donatenow Subscribe to our weekly newsletter to get the scoop on new episodes at Revealnews.org/weekly Connect with us onBluesky, Facebook and Instagram Learn about your ad choices: dovetail.prx.org/ad-choices

Generalizations about ADHD haven't done girls any favors. ADHD often manifests very differently in girls than in boys. What causes parents, educators, and even doctors, to view the symptoms of ADHD differently with girls? We know that masking, and even variations in environments, often cause symptoms to be missed. How is that happening? We're revisiting the subject and chat with Stephen Hinshaw, a Distinguished Professor of Psychology at UC Berkeley and Professor of Psychiatry and Behavioral Sciences at UC San Francisco. Find out more about building neurodiversity-affirming schools, and about the courses we'll be offering soon, here. Stephen P. Hinshaw is Distinguished Professor of Psychology at UC Berkeley and Professor of Psychiatry and Behavioral Sciences at UC San Francisco. His focus is on developmental psychopathology, child and adolescent mental health (particularly ADHD), and the use of clinical trials to understand underlying mechanisms. He also actively investigates mental illness stigmatization and attempts to reduce such stigma. Hinshaw has authored over 400 articles, chapters, and commentaries, plus 12 books. He has won numerous national and international research awards, including the James McKeen Cattell Fellow Award from the Association for Psychological Science, the Distinguished Scientific Contributions Award from the American Psychological Association, and the Sarnat International Prize in Mental Health from the National Academy of Medicine. He was inducted into the American Academy of Arts and Sciences in 2021. His extensive media coverage includes the New York Times, Washington Post, Wall Street Journal, Today Show, CBS Evening News, ABC World News Tonight, and many more. BACKGROUND READING Berkeley, research, website, Straight Talk about ADHD in Girls: How to Help Your Daughter Thrive The Neurodiversity Podcast is on Facebook, Instagram, BlueSky, and you're invited to join our Facebook Group.

Today we are revisiting an October 2023 Berkeley Talks episode in which Ezra Klein, a New York Times columnist and host of the podcast The Ezra Klein Show, discusses the difficulties liberal governments encounter when working to build real things in the real world. He joins in a conversation with Amy Lerman, a UC Berkeley political scientist and director of the Possibility Lab.“To have the future we want, we need to build and invent more of the things that we need,” begins Klein, who has since published the 2025 book Abundance with co-author Derek Thompson. “It's so stupidly simple, so obvious, that it seems weird there could be any need to write articles or podcasts or truly, God forbid, a book about it.” “And yet,” he continues, “the story of America in the 21st century — more than that, the story of liberalism, and particularly California liberalism — is a story of chosen scarcity.” Klein argues that while liberal governments are ambitious in their aims, like addressing climate change, building affordable housing or expanding infrastructure, they are often hampered by the very procedural safeguards and checks designed to protect rights and ensure public input.There are things, he says, that we have an abundance of now — flat screen TVs, iPhones — but we need more of the things that will make real the world in which many of us want to live: “A world where we're not cooking the planet, a world where a firefighter who works to keep San Francisco from burning down can live in the city he works on the daily to save, a world where there is access to the medical care and medications that people need. I care about working backwards from the world I want to the things we need to get there.”This event took place on Oct. 5, 2023, in UC Berkeley's Zellerbach Hall. It was co-presented by Cal Performances and UC Berkeley Graduate Lectures as part of the Jefferson Memorial Lecture Series.Watch a video of the event on the Graduate Lectures website.Listen to the episode and read the transcript on UC Berkeley News (news.berkeley.edu/podcasts).Music by HoliznaCC0.Photo by Lucas Foglia. Hosted on Acast. See acast.com/privacy for more information.

Show notes (Why We Sleep book summary)⁠ / ⁠Free Full Audiobook⁠ / ⁠PDF & Infographic⁠ / IN THIS EPISODE: Sleep is a complex, essential biological process that significantly impacts physical health, mental function, and emotional regulation, and understanding and prioritizing it can dramatically improve overall human well-being. Read 1 million books in minutes. For free. Visit getstoryshots.com to get started. TOPICS: sleep, Circadian rhythm, health, Dreams, mental health, Neuroscience KEY FIGURES: Pixar, National Institutes of Health, NBA, Atomic Habits, World Health Organization, Centers for Disease Control and Prevention, Harvard Medical School, Why We Sleep, NFL, Matthew Walker, UC Berkeley, Deep Work, Einstein, StoryShots SUMMARY: Matthew Walker's book 'Why We Sleep' reveals a critical insight into the profound importance of sleep for human health, highlighting that most adults in developed nations fail to get the recommended eight hours of sleep. The book explains the complex biological mechanisms behind sleep, including the 24-hour circadian rhythm regulated by the suprachiasmatic nucleus and the buildup of adenosine that creates sleep pressure, demonstrating how these systems interact to govern our sleep-wake cycles. Walker emphasizes that sleep is not a passive state but a critical biological process with distinct stages-NREM and REM sleep-each serving unique functions for physical and mental restoration. During these stages, the body performs essential tasks like tissue repair, memory consolidation, emotional processing, and clearing toxic proteins from the brain. Sleep deprivation has severe consequences, including increased risks of chronic diseases like cancer, heart disease, and diabetes, as well as significant impairments in cognitive function, emotional regulation, and mental health. The book also explores how modern society has created a 'sleep loss epidemic' through factors like artificial lighting, technology, work schedules, and cultural attitudes that devalue sleep. Walker provides practical strategies for improving sleep quality, such as maintaining a consistent sleep schedule, creating a cool and dark sleeping environment, avoiding caffeine and alcohol before bedtime, and establishing a relaxing pre-sleep routine. By understanding and prioritizing sleep, individuals can dramatically improve their overall health, cognitive performance, and emotional well-being. KEY QUOTES: • "Sleeping less than six hours a night is a form of self-inflicted harm that damages every system in your body." - Matthew Walker • "Dreams are not the byproduct of sleep, but rather its purpose, nature's best attempt at emotional first aid." - Matthew Walker • "Our modern world is perfectly designed to disrupt sleep, creating the most sleep deprived era in human history." - Matthew Walker • "The amygdala, your brain's emotional center, becomes 60% more reactive without proper sleep, while the rational prefrontal cortex becomes less active." - Matthew Walker KEY TAKEAWAYS: • Sleep is essential for physical health, with chronic sleep deprivation dramatically increasing risks of serious conditions like cancer, heart disease, and diabetes • Sleep consists of different stages (NREM and REM), each serving unique functions for mental and physical restoration, including memory processing, emotional regulation, and tissue repair • Modern society has created a sleep loss epidemic through artificial lighting, technology, work schedules, and cultural attitudes that devalue sleep • Dreams during REM sleep are crucial for emotional processing, stress reduction, and enhancing creativity by forming unique connections between ideas • Sleep patterns naturally change throughout life stages, with significant variations in sleep needs and rhythms from infancy to old age • Lack of sleep impairs cognitive function, reducing concentration, memory, and decision-making abilities while increasing emotional reactivity... Learn more about your ad choices. Visit megaphone.fm/adchoices

Jessica Richter is a medtech executive and a board member with MedtechWOMEN. Jessica shares her inspiring journey from B2B sales to becoming a leader in the medtech industry, including overseeing a wide range of vital functions such as clinical trial strategy, regulatory affairs, and market access. Jessica provides insightful advice on overcoming common industry challenges, and underscores the value of quality systems, expert team-building, and fostering a supportive network for women through MedtechWOMEN.   Guest links: https://www.linkedin.com/in/jessica-richter-5aa43517/ | https://medtechwomen.org/ Charity supported: Save the Children Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host: Lindsey Dinneen Editing: Marketing Wise Producer: Velentium   EPISODE TRANSCRIPT Episode 059 - Jessica Richter  [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I'm excited to introduce you to my guest, Jessica Richter. Jessica is the Executive Vice President and General Manager at Veranex, a global provider of end-to-end solutions that accelerate MedTech innovation through deep expertise and integrated resources. As the leader of Veranex's contract research organization and consulting services business unit, she oversees clinical trial strategy and execution, clinical data services, regulatory affairs, quality and compliance, market access and reimbursement. She also manages operations, client engagement, business development and performance tracking. A seasoned leader in medical devices and diagnostics, Jessica has extensive experience in software as a medical device, surgical innovation, oncology, aesthetics, cardiology and gastroenterology. Her tenure at Medtronic and Becton Dickinson shaped her expertise in commercialization, sales strategy, physician education, patient advocacy, and change management. Beyond her current role, Jessica serves on the boards of medtech, women and UCLA's technology development group. She actively advises startups, accelerators, and universities, including medtech innovator UC Berkeley's Master of Translational Medicine Program, the Mayo Clinic's Executive Steering Committee for the Surgical Innovation Summit, and UCLA BioDesign.   Thank you so much for being here, Jessica. I'm so excited to speak with you. [00:02:15] Jessica Richter: Likewise, Lindsey, thank you so much for having me. [00:02:18] Lindsey Dinneen: Of course. Well, I'd love if you wouldn't mind sharing a little bit about yourself and your background and what led you to medtech. [00:02:26] Jessica Richter: Awesome. Yeah, happy to. So, I was born and raised in California. I am the youngest of three girls and my entire family is really in the healthcare delivery field. So both my grandfathers were surgeons. My mother is a nurse. Both my sisters are clinical psychologists. And so when I went to school, I had aspirations at one point to get into medicine, and then through a really challenging organic chemistry class, kind of started to realize that maybe the practice of medicine wasn't where I belonged. And so I initially graduated from Berkeley, had my sights set on potentially doing something in communications, and started off in business to business sales in the telecom industry. So as far from medtech as maybe one could think. Had some experience with software, this is when Blackberries were a thing, if you remember those. And then a friend of mine was a recruiter and reached out and said, "Hey, I, I know that you're into medical and into medicine, and that was something you were interested in. Have you ever considered a career in medical device sales?" And frankly I didn't even know that that existed. I mean, this was 20 years ago, so this was before, you know, internet and all of those things existed, obviously, but it wasn't as pervasive as it is now. And so I wasn't even aware that these jobs existed. The fact that you could be working on the delivery of care but not be a healthcare provider was an eyeopening moment. And so I got in and started actually working at a surgical company called Deval. It's part of CR Bard, which is now part of Becton Dickinson, and I cut my teeth in medical device sales. And then I went on to work in a commercial role within other companies Given Imaging, Covidian, Medtronic. I ascended to sales leadership, working with key opinion leaders, working on the patient advocacy side. And then about eight years ago, I had the opportunity through an organization that we'll talk a little bit more about, called MedtechWOMEN, that I was involved in to learn about a consultancy that was looking for a head of business development marketing. It was a small group called Experian Group. I joined them and then within nine months was promoted to Chief Operating Officer, which was a position that I absolutely loved because we were working on the pre-commercial side of things and regulatory quality systems, clinical trials. And I had always had experience in the post commercial side. So eyes open to what happens, everything leading up to commercial. And I got a masterclass from my colleagues there, learning so much about what happens again, pre-commercial. But then one of the other things that came out very quickly is I've always been someone who loves operational efficiency. And I know that's not sexy or cool, but I just like seeing something that isn't working optimally and get it working optimally is something that brings joy. So I had the opportunity to do that within Experian Group, and then really help the organization, which was already very successful, go from a very successful kind of local consultancy to a much larger, broader group with a broader footprint, more global client base. And then we were acquired by the firm that I currently work with called Veranex, and that really exploded capabilities of what was a 50% consultancy to now over a thousand people with a much broader global reach in the US, in Europe, and in India. [00:05:36] Lindsey Dinneen: Wow. That is incredible. Well, first of all, thank you for sharing your story and your background and all the amazing things that led you to where you are right now. That's incredible. So many questions, in a good way. But let's dive in a little bit about, yeah, so, so tell us a little bit more about your role right now, and what are you excited about as this consultancy continues to grow and new opportunities arise. What's on the future for you? [00:06:02] Jessica Richter: So now I lead one of three business units here at Veranex. So I lead our CRO and Consulting Services Business Unit, and that encompasses regulatory, quality, and clinical, as well as commercial strategy, market access reimbursement, things like coding, coverage, payment. So we help mid-size, early stage, and some of the largest strategic medtech companies, as well as some biopharma as well with companion diagnostics, navigate sometimes the tumultuous waters needed to bring a device from inception all the way through to commercialization. Veranex also has two other business units in preclinical as well as extensive design, development and engineering. So there's leaders in each of those capacities. And what we do on CRO and consulting services is really consultative. So we work with clients to develop strategies in all of these areas, and then we roll up our sleeves and work alongside them to make sure that those strategies are actually executable, so to help them along the way. And some of our clients have teams, so it's strategic and we're advisors. Other clients, if they're early, early, may not have extensive expertise or the ability to build out teams in that way. So we go in, or our team goes in, and really provides them that support along the entire continuum. It's interesting, just today, we have a client we've been working with for two years. They're in Switzerland, but they've been working with our US and global team. They just got news from FDA that they obtained FDA clearance. And I'll tell you, I think our team is as excited as theirs because, when you're in a company, it's all that you're living, breathing, doing. When you're consulting, you're a little bit at an arm's length. So when our clients achieve their results, and it's their work, but in concert with ours, the feeling of accomplishment really is just, it's one of those that's explosive. So we've celebrated that. We ring a bell. We'll share a lot, we'll do some marketing around it with this client. But it's really fun. That's the part that really drives not just me, but members of our team as to "How can we help more companies get more products to patients?" [00:07:58] Lindsey Dinneen: I love that. First of all, congratulations, that's exciting, and I'm thrilled for your clients and for you guys because it matters so much and what a great milestone. So that's wonderful. But yeah, so I'm curious, you've seen a lot of different sides to medtech and to the business side of things, and I'm curious what are some potential stumbling blocks that you have seen that companies, especially when they're perhaps a little bit younger or earlier on in the process, what are maybe one or two stumbling blocks that you see that you think, "You know what, hey, if we put a little bit of thought into this, we can overcome this very easily, but we need to be thinking about this from the start." [00:08:36] Jessica Richter: Okay. There's two things. One of them is gonna be a shameless plug, but I swear it's true, and that's quality. I think companies don't focus enough on quality systems 'cause it's just not the fun or sexy thing, but it's literally where we see companies struggle because they think about it too late. They do just in time. They think an EQMS is the answer, and it's not the only answer, it's a component. So quality would be the short answer. The longer answer is people. So what we see is oftentimes, people, especially in a cost constrained environment, which we are today, where fundraising is tough, people do need to be financially astute as far as what they're spending and how they're spending it. But sometimes you get more by spending a little bit more to get the right advice. So for example, if somebody is expert in engineering or expert in regulatory, excellent. Know where your expertise is not, and then supplement. So either hire a consultant or bring on an employee or have a member of your board that can advise them that way. More often than not, we see people trying to just kind of figure it out as they go, which isn't a bad strategy, but there are critical decisions and inflection points along the way. For example, if you're developing a clinical trial, thinking only about your regulatory strategy and not about your commercial goals or the claims you're going to make, you are gonna have to ultimately spend twice as much when you have to do secondary studies that you could have avoided by including that in endpoints. So there's little things like that along the way where if you don't know what you don't know, it's really difficult to see those hurdles. It's helpful to bring in people, even in an advisory capacity, to help you say, "Okay, these are the hurdles that you're gonna face." You're gonna have new hurdles that maybe that you won't know or people won't know, but it's really making sure that you surround yourself with experts in those key areas. [00:10:25] Lindsey Dinneen: Mm. That's great advice. Experts in those key areas. Well, speaking to the advisory point, I'd actually love to talk about your involvement with MedtechWOMEN, and tell us a little bit about that organization and how it serves women in this industry. [00:10:39] Jessica Richter: Absolutely. Thank you for asking. It's something that I could literally talk about for this entire podcast. So, I alluded to it earlier, but MedtechWOMEN, I got, and I say "roped in" lovingly, but I was introduced to this organization, gosh, maybe a decade ago now when I was at Covidian and then Medtronic, and a mentor of mine, Amy Belt Raimundo, was one of the founders of MedtechWOMEN. And she had mentioned to me, because there weren't a lot of female leaders within that section of my business at the time, so I was paired with her and it feels like kismet because she was this spark of like, this is what badass female leadership looks like. She knew her stuff, she was really focused on the issues. She made time and said yes anytime I had a question or wanted to meet. Our conversations were really meaningful and actionable. Sometimes we just talked as friends. It wasn't always so agenda based, but she introduced me to MedtechWOMEN and shared with me that there's this organization. It's all volunteers. It's kind of membership based and it's literally women getting together talking about the issues in our industry. And it wasn't as focused on things like work-life balance, which quite frankly is a challenge, no matter what your gender is. There are great forums for talking about work-life balance and how you prioritize your health and your mental wellbeing, and that is really, really important. But some of the events that I had gone to as far as women in leadership or women in medtech were really focused on those things and that wasn't what I wanted to talk about. I wanted to see incredible pioneers or trailblazers in our industry talking about the things that mattered in industry and sharing their perspectives. And that's exactly really the thesis of MedtechWOMEN. And so it was an organization founded over a decade ago. It started really as just an annual event, this MedtechVISION event, where we brought women together on a podium talking about the issues impacting healthcare today. It evolved. So after a couple of years and a couple of different topics, what we started to see is that there was a real thirst in the community that we had beyond just that individual or that one time a year we got together for the event. And so we developed a kind of MedtechWOMEN 2.0. We brought on an Executive Director. And we essentially launched a much, much grander vision of what MedtechWOMEN was. So it included membership. It included mentorship, so formal pairings. We created a board of directory, kind of a pathway to get to more women on boards. We also have local events, networking events, virtual events in partnership with our sister organizations like MedTech Color and Diversity by Doing. And then of course we still have our annual event. And then just this past month we actually brought on a new executive director. Her name is Yvonne Bokelman. She is a longtime industry veteran, tremendous leader in medtech, and someone who's really passionate about the organization, the mission, the vision. So we're excited to see what she will do in her role here. [00:13:38] Lindsey Dinneen: Yeah. That's incredible. Thank you so much for sharing a little bit about the organization and its history and who it is serving, and it really resonated because I agree with you that there's wonderful platforms for being able to talk about some of the. Some of the topics that tend to come up quite a bit for women, especially women leaders, and I love the fact that you are fully acknowledging that those things are great as well, but that your focus is a little bit different. And so I'm curious, what are some interesting stories or things that have happened maybe unexpectedly from this network of incredible women supporting each other, learning from each other. Can you share a little bit that? [00:14:17] Jessica Richter: Oh yeah, absolutely. And I'll tell you, many of us that have been members for a long period of time will attest to the fact that job opportunities come via this network, learning opportunities, sales and business opportunities. I mean, we network in the same way that we would in any other conference or any other meeting, but deals certainly have gotten done within and at MedtechWOMEN and MedtechVISION events. But most importantly, and one of the things that I always tout, is that MedtechWOMEN is a sisterhood that will take that call. And what I mean by that is if you have a question, if you need to phone a friend-- going back to what we were talking about earlier of that network of you don't know what you don't know, but somebody probably does-- within MedtechWOMEN, someone definitely does. And so what we encourage our members and our mentors and anyone that's a part of the organization to do is reach forward and reach back. And so when I say take that call, if someone calls-- and I just had literally three conversations in the last three weeks-- with more junior people looking for career advice or wanting to have a question about regulatory or their thinking about a decision point in their job, and what should they do? I always take that call and, you know, we're all busy. We all have things to do, but that 30 minute conversation can have a really big difference. And I know for me, likewise, when I have a question, when I'm coming up against something where it's helpful to have a thought partner, sometimes you want that outside of your own company, or outside of your boss, or outside of your team. And so the MedtechWOMEN Network is incredibly powerful and very supportive. And in my experience, and I've tried it both ways, we will always take that call. [00:15:53] Lindsey Dinneen: Oh wow. That's incredible. So, okay, so mentorship and leadership is obviously a key component of your life, something that you're passionate about. From your own experience as a woman in this industry, are there any things that come to mind that you would say, just pieces of advice-- let's say for other women who might be younger in their career and they're looking to grow, they're looking to become leaders, they're looking to become maybe thought leaders, or own their own company, things like that-- what are some things that you might suggest to them from your own experience would be helpful? [00:16:27] Jessica Richter: Oh yeah. It's, it's a great question, Lindsey, because there's a lot of things. I wish we could just mind share. First and foremost, I would tell women to go for it. I think sometimes we self-sabotage or hold ourselves back if we don't have all of the information or feel like we're a hundred percent qualified. And there's been tons of studies that demonstrate that. So first and foremost, go for it. I had this conversation with one of my mentees who was taking on a new role and I said, "It's okay that you're feeling this way or that way. Do it and do it scared." Like it's okay to not feel like you have all of the confidence, right? And it doesn't mean fake it till you make it, although there's a little bit of that too. But I would say don't let fear hold you back. So that would be the first piece of it. The other piece of it is make sure that you have, really, your own board, meaning advocates, mentors, coaches, thought partners, people that you can reach out to and rely upon. And that has to work both ways. I will tell you, I have learned as much from mentees as I have learned from mentors. And so recognizing that knowledge is shared both ways, no matter what your seniority is. For people that are junior, they have their on the pulse of things that I'm not as privy to, and sometimes I feel, feel that even more strongly. Likewise for people that have been in this industry 40, 50 years, they have institutional knowledge that I only wish that I had. And so, being at this midpoint in my career, I'm sandwiched between both and really appreciate, so I would implore people that are hoping and wanting to pursue leadership, go for it. [00:18:00] Lindsey Dinneen: Yeah. Thank you for that. I, I love that advice. I really appreciate it. So, you have had such an interesting career and going from communication and sales, and then to this new role and Chief Operating Officer, all these cool things. For your own leadership style, what would you say are maybe one or two key things that you have found to be really helpful for you as a leader in the industry in the way that you approach the people that you lead? [00:18:30] Jessica Richter: Another great question, Lindsey. So I would say, well --first maybe I'll share some lessons learned 'cause I've made a ton of mistakes. So I think one of the things that I didn't appreciate early on as a leader that I definitely appreciate now, is that we all have our own lens, our view with which we take on and see the world, and that's the view in which, you know. And so as a leader, initially, my thought was, "Well, everyone kind of sees and feels it this way with their own flavor." That is not true. Everyone has their own view and that's really shaped by their family, their background, their culture, lots of different aspects. And so I think for me, some advice as a leader would be, be humble, take the time to really seek to understand, and then, even if you are heightening your communication, multiply that times three or four and then you're probably scratching the surface, 'cause people need to hear things different ways, multiple times. And it doesn't mean you need to micromanage or drill things down, but when you're leading an organization and bringing people along on a change, especially, it is important that people understand the why, the who, the what, the how come, and that they hear that re repeatedly so that they can understand it, they can buy into it, and that you're creating an environment to make sure that their questions are addressed. So, lesson learned kind of recommendation on the leadership piece. I think the other just piece of advice is that sometimes people aspire to leadership because they think it's glamorous or there's gonna be a lot of money there, or it looks like the leader doesn't have to do that much work, they're just delegating. What I would say is leadership is not glamorous. It's often thankless. It's super hard. I work tons of hours and I love the team that I work with, and so for me the why is that. But if you are not loving that, don't do that. There's plenty of opportunities that you can contribute meaningfully as an individual contributor or a principal or a subject matter expert, and that's great too. So know that if you want to lead people and be involved on that side of leadership, I welcome it. I think it's fantastic. I think there's a lot of people that get into it with a misconception of what it will look like. And I'll tell you it's worthwhile, but it's hard. [00:20:43] Lindsey Dinneen: Yeah, absolutely. Yeah, when you were talking about that it, the glamor side of things, I just remember so vividly and I, I joke about it because I think it's funny-- but very quickly, I used to own my own dance studio and I built that from the ground up. And people would say things to me like, "Oh my goodness. What you're doing, you're living your dream. That's amazing! Oh my gosh, how cool is that?" And inside, I'm like, "Ha, yeah, I mean, I spent the first two hours as the janitor this morning, and then the next two hours as the CEO. And then, you know..." And it's funny, but it's true, you wear a lot of hats as a leader and sometimes your job is literally getting down into the nitty gritty and cleaning up, and that's fine too. So I love that. [00:21:24] Jessica Richter: My quip is always from the janitor to the GM, like, "What needs to get done? There's no task too big or too small." And ultimately, I think that what you described in yourself, and I love that, is servant leadership, right? Like for me, I've always responded well, when a leader isn't above any task and doesn't ask for something that they themselves would not be willing or aren't willing to do along with their team member. And so again, that's, that's not the definition of leadership, but in my eyes, that's a definition of leadership that really resonates with me. [00:21:55] Lindsey Dinneen: Mm-hmm. I agree. Yeah. Well, speaking of stories and those kinds of fun things too, are there any that stand out to you, perhaps along your career or with MedtechWOMEN, or anything really, that just affirm to you that, "Hey, I am in the right industry at the right time, doing what I should be doing?" [00:22:14] Jessica Richter: Oh yes. So there's a couple of different specific examples. So firstly, one of the things that has happened as of late, and I feel like-- not to get too woo or California on you-- but these synchronicities where you'll be thinking about something or remembering something, and suddenly a project and people come together around it-- and again, I think that's part of the power of the network. But there was a friend of mine that I had run into at a conference, we were talking about a specific aspect of their business that was really needing some, some development, and it turned out that after that conversation, literally not a week later, I got a call from a prospective client that was interested in working in this specific space. We were able to connect them with this person that was in need of that exact thing. And it was with software and with AI and so a partnership was forged and now they are literally about to embark in this really explosive and announcement will be forthcoming about it. But there's so many examples of little nuances and synchronicities like that, that again, happen because of staying open, staying curious, that powerful network right place, right time. But I also think it's the magic of our industry. It's really small. People sometimes fail to appreciate because you have these large organizations that are hundreds of thousands of people, but the leaders within the organization are fairly connected and tight. It's really an interconnected ecosystem. So that's just kind of one broad example. There's also other really small examples of the power, I think, of MedtechWOMEN in just how it ignites and how it brings people together, especially across senior and junior roles. So when we do our networking events, we try to do them regionally, just to try to bring different people together. And you can have like the CEO of sometimes a large organization, like Lisa Earnhardt from Abbott is a member and an active participant. She often will come to events talking to someone who's their very first year in medtech. And when you see these examples of sponsors of ours really showing up and demonstrating a commitment to giving back, and you see these people that are junior that may not even know the seniority of the leader that they're speaking to, recognizing that we're all people at the end of the day, trying to really ideally propel healthcare and help patients in their journeys to health and wellness. And so when you see examples of those sparks and those little ignites, it reinforces why we're here, what it is we're doing, and really the power of the organization. [00:24:41] Lindsey Dinneen: Yeah! Well, I think that the more times that you get to see those connection points, and those synergies or whatever we wanna call them, I think that that does impact us in a way that goes, "Yeah, the work that I do matters and it's impacting people's lives and maybe in very different ways." So some of it is, yeah, that end user and that patient, and oh my goodness, what this device can do for them and their quality of life. And sometimes it's the person behind the invention and what does that journey look like for them personally and the impact on their own family and their life. So I love hearing about those connection points. [00:25:16] Jessica Richter: Well, and that's the joy of working also with, I mean, large strategics for sure, but the startup companies, oftentimes it's a physician and engineer. The physician is seeing the unmet need because of the patients coming into their clinic. They're feeling hopeless 'cause they can't address it, but also empowered because they know what to do. So those are the really fun, kind of feel good projects, especially because there is no one better equipped than a clinician, right, to say, "Okay, here's the gap." Engineers can help to design and develop, but oftentimes that's where the teams are sort of left in the lurch to say, "Okay, what do we do from here?" And so it is incredibly powerful to enable these innovators, no matter what their backgrounds are along that journey. And it's not a quick one as you know, being on the manufacturing side. It's not something that's quick or easy. It's not something that is a high success rate. And when it works, there is no better feeling. When you commercialize a device or when you get it through the FDA, that's just the start. When it's actually used in patients and you start to hear those patient advocates and those stories, and you expand indications and are able to help more patients, that's the thing that makes it worthwhile. And when the going gets tough, 'cause it does that, those are the stories, right, that really inspire us to continue. [00:26:33] Lindsey Dinneen: Yes, absolutely. Amen to that. So, okay, so I have so many thoughts swirling around, but I do want to pivot the conversation a little bit just for fun. So imagine that you were to be offered a million dollars to teach a masterclass on anything you want. It can be within your industry, but it doesn't have to be. What would you choose to teach? [00:26:53] Jessica Richter: Oh, I love this question. I'll try to make it not about our industry 'cause it's something I've been working on a lot lately, and it's a testament to patience, which is something that I think we could all use more of, but I could definitely use more of. So we rescued a dog in Covid. She's a Doberman pit mix. Her name is Poppy and she's delightful. And she was severely neglected. So when we got her, we knew she was really shut down and that we would have to do work to bring her out of her shell. My husband and I don't have kids. We have a quiet home. I knew that we could take that on. And so while I won't say I am the expert, what I have done in the four years we've now had her, is extensively worked with her on the, what I would call the "Art of the Dog Walk." So we have learned how to really master exercise, training, and discipline as a way to show affection, 'cause for a dog that shut down like that, that's really what she needed to thrive. It was humbling and very educational for me. I've always been a huge animal lover. I used to volunteer when I had a lot more time with an animal rescue. And so I was able to parlay that and work with a trainer really on honing those skills so that Poppy could not just be social in the world, but be less shut down. So it would be so fun to share a masterclass on that 'cause I had so many reflections and learnings on patience. The art of going slow, the art of taking in the world, of just slowing that down, not being on my phone, right, being really present with her. And I sort of joke with my husband, I feel like now when I walk her-- I dunno if you've seen the movie "Avatar"-- but like we connect our avatars and we like go on into this world, and it's meditative. It's our morning practice and it's something that for me has been incredibly rewarding, and challenging, and a huge learning experience that, that I would love to share. [00:28:50] Lindsey Dinneen: Oh, that's wonderful. Oh my goodness. Yes. I am a huge dog lover, so anytime someone's telling me about their dog, it's just instant happiness. [00:28:59] Jessica Richter: Likewise. And for my, my favorite thing that it will always bring a smile to my face is the unlikely animal friends, like if you see like a squirrel a dog or a kookaburra or something, you're like, "Ahh!" [00:29:10] Lindsey Dinneen: It's so cute. It's precious. Yes. I love it. And to me it reinforces, "Hey, we can actually all get along if we try." I mean, I know it's a little different in the animal kingdom, but still, I still love that. Oh my goodness. Great. Well then, how do you wish to be remembered after you leave this world? [00:29:32] Jessica Richter: You know, legacy is something, that I think is important. It's funny, I've been working with my niece on her college essays and college admittance, and reflecting back to my views when I was 18 versus my views today in the world now. And even speaking to my mom about legacy, 'cause it's something, you know, she's approaching her eighties that she thinks more and more about. So it's conversations that we have a lot. I really would love to be remembered as an enabler, as someone who really enables those around me to be successful, to achieve more, to obtain what they want right to, to drive forward. I love being around creative people and innovators and people with really expansive imaginations, and I think my superpower is kind of capturing and enabling those things. So it would be great to be able to enable more people around me. And that's true with patients and healthcare and the clients that we support as well. You know, one of the things that has always been pointed out to me-- and again, my grandfather was a huge proponent of this-- is when things aren't going well in the world, you can focus on what's going wrong or you can look for the helpers. And so, as a surgeon, he was one of those helpers. And so I think he ingrained that in me very early on. And so I'd love to be remembered as someone who is a helpful enabler. [00:30:51] Lindsey Dinneen: Hmm. Yes. That's a beautiful legacy. I love that. [00:30:54] Jessica Richter: I am curious, Lindsey, I know this is like, you're the, you're the interviewer, but how would you like to be remembered? [00:31:02] Lindsey Dinneen: Oh, thank you for asking. First time! You know, there are so many things, so many things that I love doing for other people. But I really actually resonated with your idea of enabling. And I would say mine is very similar. And that is that I love helping people achieve their dreams. And that can look like lots of different things to lots of different people. So it's when I'm working with a company, it always started with one person's idea, right? All these big companies started off as this tiny little one person's idea that became something. And I think just helping that, those sparks, especially when maybe they're eager, but they're not quite ready. They're scared, they're nervous, they're whatever, and helping them see a clear path to achieving those dreams and goals is one of my favorite things. And whether that's just a personal, I wanna run a marathon, I don't even how to know how to get started, or whether it's, I have this great idea for a book, but I am concerned about, like, "Nobody will read it, no one will care." Well, that's not the point. Let's start somewhere. And so I think for me, it's about empowering people to live the life that they want to live and hope that they can live. That's what I would love to be remembered for. [00:32:16] Jessica Richter: Well, that's beautiful. I hope that via this and the other things that you're doing, it seems like you're already on that track. [00:32:22] Lindsey Dinneen: Well, thank you. I appreciate that. I really appreciate you asking me too. Thank you. Well, and then final question, and you've sort of perhaps alluded to this-- I'll see if it's different than your first time-- what is one thing that makes you smile every time you see or think about it? [00:32:37] Jessica Richter: Oh, well, definitely the unlikely animal pairings for sure. [00:32:41] Lindsey Dinneen: Yes. [00:32:42] Jessica Richter: Anytime with family. Family is super important to me. So anytime I can spend time with our family, that is for me, a smile doesn't go off of my face. And also kind of what you said, celebrating other people's wins. And I celebrate my own as well-- I think it's important that we do that-- but there is nothing like, it's a grin, like when someone on our team has an accomplishment, the grin is twice as big, right? Because you just, to see that reflected, that success, that attainment, that win reflected for the people that you work alongside, that brings a smile to my face every time. [00:33:20] Lindsey Dinneen: Yeah, nothing quite like it, and it's so powerful. Yeah, huh. Oh my goodness. Well, this has been an amazing conversation. I don't really want it to end, but I know we have other things we have to get to today, so I just wanna take some time to say thank you so very much for being here with me, Jessica. Thank you for sharing all about your incredible career so far and all the exciting things that are to come, and speaking to MedtechWOMEN and that incredible organization. So I'm really excited for our listeners who might not have been familiar with it to go check it out, lots of opportunity there. And gosh, I just wish you the most continued success as you work to change lives for a better world. [00:34:01] Jessica Richter: Thank you, Lindsey, for hosting and I would encourage anybody who's unfamiliar with MedtechWOMEN, if you're new to industry or if you've been here a while, there is a place for you within MedtechWOMEN. Membership is super low cost. It's $150 for standard membership a year, $75 for junior members. You can follow us on LinkedIn, but highly, highly encourage everyone to join the network. And thank you for the opportunity to share a little bit more about MedtechWOMEN today. [00:34:26] Lindsey Dinneen: Of course. We are so honored to be making a donation on your behalf as a thank you for your time today to Save the Children, which works to end the cycle of poverty by ensuring communities have the resources to provide children with a healthy, educational, and safe environment. So thank you so much for choosing that charity to support. Thank you also to our listeners for tuning in, and if you're feeling as inspired as I am right now, I'd love it if you share this episode with a colleague or two, and we'll catch you next time. [00:34:57] Jessica Richter: Thanks, Lindsey. [00:34:59] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

Reliable software shouldn't be an accident, but for most developers it is. Jeremy Edberg, CEO of DBOS and the guy who scaled Reddit and Netflix, joins Corey Quinn to talk about his wild idea of saving your entire app into a database so it can never really break. They chat about Jeremy's "build for three" rule, a plan for scale without going crazy, why he set Reddit's servers to Arizona time to dodge daylight saving time, and how DBOS makes your app as tough as your data. Plus, Jeremy shares his brutally honest take on distributed systems cargo cult, autonomous AI testing, and why making it easy for customers to leave actually keeps them around.Public Bio: Jeremy is an angel investor and advisor for various incubators and startups, and the CEO of DBOS. He was the founding Reliability Engineer for Netflix and before that he ran ops for reddit as its first engineering hire. Jeremy also tech-edited the highly acclaimed AWS for Dummies, and he is one of the six original AWS Heroes. He is a noted speaker in serverless computing, distributed computing, availability, rapid scaling, and cloud computing, and holds a Cognitive Science degree from UC Berkeley.Show Highlights(02:08) - What DBOS actually does(04:08) - "Everything as a database" philosophy and why it works(08:26) - "95% of people will never outgrow one Postgres machine"(10:13) - Jeremy's Arizona time zone hack at Reddit (and whether it still exists)(11:22) - "Build for three" philosophy without over-engineering(17:16) - Extracting data from mainframes older than the founders(19:00) - Autonomous testing with AI trained on your app's history(20:07) - The hardest part of dev tools(22:00) - Corey's brutal pricing page audit methodology(27:15) - Why making it easy to leave keeps customers around(34:11) - Learn more about DBOSLinksDBOS website: https://dbos.devDBOS documentation: https://docs.dbos.devDBOS GitHub: https://github.com/dbos-incDBOS Discord community: https://discord.gg/fMqo9kDJeremy Edberg on Twitter: https://x.com/jedberg?lang=enAWS Heroes program: https://aws.amazon.com/developer/community/heroes/

Augustus Doricko is the founder and CEO of Rainmaker, a next-generation cloud seeding company. He is a UC Berkeley dropout, Thiel Fellow, and member of the El Segundo hard tech scene. Rainmaker utilizes weather-resistant drones to enhance precipitation and employs novel radar hardware to quantify the amount of man-made precipitation generated. Rainmaker's first priority is reversing the desertification of the American West, and ultimately to terraform deserts into abundant, green, arable land. Augustus Doricko is the founder and CEO of Rainmaker, a next-generation cloud seeding company. He is a UC Berkeley dropout, Thiel Fellow, and member of the El Segundo hard tech scene. Augustus Doricko Links: Rainmaker – ⁠https://www.rainmaker.com⁠ X – ⁠https://x.com/ADoricko⁠ LinkedIn – ⁠ / augustus-doricko-660b20145⁠ Substack – ⁠https://substack.com/@doricko⁠ 00:00 Introduction & Weather Manipulation Overview 02:25 Operation Popeye & Historical Context 04:20 Guest Background & Regulations 16:17 Career & Entrepreneurial Journey 26:08 Space Experiments & Future Tech 30:13 Weather Modification in Vietnam 36:52 Global Players & China's Advancements 41:51 Public Skepticism & Misconceptions 42:06 Cloud Seeding & Geoengineering 49:25 Environmental Concerns & Innovation 01:12:44 How Cloud Seeding Works 01:20:38 Making Rain & Snow: The Science 01:26:14 Water Crisis & Climate Solutions 01:36:21 Future of Atmospheric Engineering 01:55:00 Risks, Ethics & Geopolitical Threats 02:00:03 Final Thoughts & Future Outlook https://www.rainmaker.com/   https://itsyahushua.com/2025/07/06/making-it-rain-in-texas-with-the-rainmaker-augustus-doricko-the-ceo-of-rainmaker/   Sources https://westtxwxmod.com/   https://southtexasweathermodification.com/post.html   https://docs.google.com/document/d/1RyuZhsI1Y-Dzh7I2MyeG0NaDTBkB9KgW/edit?tab=t.0   https://www.tdlr.texas.gov/weather/   https://www.tdlr.texas.gov/weather/summary.htm   https://www.tdlr.texas.gov/weather/weathermodmap.htm   https://www.theguardian.com/uk/2001/aug/30/sillyseason.physicalsciences   https://www.sciencedirect.com/science/article/abs/pii/S0140196318315957   https://statutes.capitol.texas.gov/docs/AG/htm/AG.301.htm   https://www.tshaonline.org/handbook/entries/weather-modification   https://www.houstonchronicle.com/news/houston-weather/article/cloud-seeding-texas-weather-modification-19860669.php   https://twri.tamu.edu/media/3911/volume-20-summer-1994.pdf   https://rollingplainsgcd.gov/programs/weather-modification/   https://ams.confex.com/ams/17WModWMA/techprogram/programexpanded_492.htm   https://issuu.com/tdlr/docs/about_tdlr/s/12027320   https://heinonline.org/HOL/LandingPage?handle=hein.journals/baylr25&div=43&id=&page=  

After a long unexpected hiatus, SnapSessions! presents Episode 60, featuring an interview with Grammy-nominated guitarist Alex de Grassi and a SnapSessions! tribute to San Francisco Giants star centerfielder, Willie Mays—"the Say Hey Kid”, just maybe the greatest baseball player of all time. Alex de Grassi has been a guitarist since his early teens, growing up in a musical family in the San Francisco Bay Area in the 1950s and 60s. Dropping the trumpet for the guitar after being exposed to the Beatles, the Stones and Mississippi John Hurt, de Grassi attended UC Berkeley in the early/middle 70s and took a lot of music theory along with his Economic Geography major. This led to classical guitar as well as ongoing labors as a street musician from Berkeley and SF to London, and then finally a connection with Windham Hill records and to his first album, Slow Circle, which came out in 1979. Since then, Alex has released a total of 16 albums dabbling in a variety of styles from Southern soul to Bolivian folk music to classical lullabies to the Woody the Woodpecker theme. In 1998 he was nominated for a Grammy for his album Water Garden. In addition, we talk to Alex about working with neuroscientist Daniel Levitin on his “Your Brain on Music” series, musing on the possible existence of a music gene. There's also an appreciative nod to some recent work he's done with the Real Sarahs. And we find out just how many guitars Alex de Grassi actually owns. SnapSessions! also pays tribute to the NY & SF Giants' great center fielder Willie Mays who died at the end of last summer. We cover Mays' great career, his extraordinary feats as an outfielder and hitter, and offer Doug's personal experiences of seeing Willie play both in Seals Stadium and at Candlestick Park. In addition, we've uncovered some outstanding recorded highlights as well as a musical gem saluting Willie Mays from the 1950s. Hosted on Acast. See acast.com/privacy for more information.

Caregiving is the most universal of human acts. But also one of the most invisible. While caring for a child, parent or loved one can be meaningful, and life defining, it can also be exhausting and life breaking. Drawing on her groundbreaking research on baby's brains, UC Berkeley psychologist and philosopher Alison Gopnik is leading a multidisciplinary project to better understand the social science of caregiving with hopes of translating those insights into practical policies. Gopnik and policymaker Anne-Marie Slaughter join us to talk about how rethinking our approach to caregiving and how we support care providers, could lead to a better, more functional society. Guests: Alison Gopnik, professor of psychology and affiliate professor of philosophy, UC Berkeley; author, "The Gardener and the Carpenter: What the New Science of Child Development Tells Us About the Relationship Between Parents and Children" Anne-Marie Slaughter, CEO of New America, a non-profit think tank; author of "Unfinished Business: Women Men Work Family" Learn more about your ad choices. Visit megaphone.fm/adchoices

Joining us in this episode of Living Off Rentals is someone who brings clarity to one of the most confusing parts of real estate investing: financing. Christian Bachelder is the co-founder of The One Brokerage and one of the most trusted lending advisors in the real estate investing space. He is a UC Berkeley graduate, and a former chemical engineer turned seasoned investor. He now helps others invest in real estate by connecting them with the right financing strategies. Listen as he breaks down the different types of loans available to investors—from traditional mortgages to DSCR and hard money loans—and how to use them strategically to grow your portfolio. We also talk about how to qualify for your first loan, when to use each lending product, the truth about BRRRR strategy funding, and why some “creative” financing methods may be more dangerous than they seem. Enjoy the show! Key Takeaways: [00:00] Introducing Christian Bachelder and his background [02:35] From being a chemical engineer to being an investor and real estate lending [04:55] The spark that ignited Christian's obsession with real estate [08:38] Partnering with David Greene and building The 1 Brokerage [11:32] How to stay competitive with a large variety of multiple loan products [14:01] The three buckets of loans every investor should know [15:55] What is a DSCR Loan, and why do investors love it [19:27] How the BRRRR loan flow works [24:44] DSCR loan terms explained: Rates, down payments, and pitfalls [29:21] Three ways of calculating a rent [31:35] Talk to your lender first before anybody [32:48] Loan options for first-time investors [35:35] 5 proven ways to find down payment funds [43:00] Why good short-term rentals still win despite market noise [46:08] Two main things that encompass the creative financing world [52:58] Connect with Christian Bachelder Guest Links: Website: https://www.theonebrokerage.com/  Instagram: https://www.instagram.com/theonebrokerage/  Youtube Podcast: https://www.youtube.com/c/DavidGreeneRealEstate  Show Links: Living Off Rentals YouTube Channel – youtube.com/c/LivingOffRentals  Living Off Rentals YouTube Podcast Channel - youtube.com/c/LivingOffRentalsPodcast  Living Off Rentals Facebook Group – facebook.com/groups/livingoffrentals  Living Off Rentals Website – https://www.livingoffrentals.com/  Living Off Rentals Instagram – instagram.com/livingoffrentals  Living Off Rentals TikTok – tiktok.com/@livingoffrentals   

DUMPLINS: CLICK HERE for the BEST dumplings you will EVER eat. https://www.jodisdumplins.com/00:00 Intro/Headlines15:29 Football Swing Games for 202538:15 Nico Iamaleava and Dante Moore are linked in 202543:15 Three Things UCLA football Can Improve in 202557:30 What's Bruin With You? Enjoy the What's Bruin Show Network!Multiple shows to entertain you on one feed:Support WBS at Patreon.com/WhatsBruinShow for just $2/month and get exclusive content and access to our SLACK channel.Twitter/X: @whatsbruinshow        Instagram: @whatsbruinshowCall the What's Bruin Network Hotline at 805-399-4WBS (Suck it Reign of Troy)We are also on YouTube HEREGet Your WBSN MERCH - Go to our MyLocker Site by Clicking HEREWhat's Bruin Show- A conversation about all things Bruin over drinks with Bruin Report Online's @mikeregaladoLA, @wbjake68 and friends!Subscribe to the What's Bruin Show at whatsbruin.substack.comEmail us at: whatsbruinshow@gmail.comTweet us at: @whatsbruinshowWest Coast Bias - LA Sports (mostly Lakers, Dodgers and NFL) with Jamaal and JakeSubscribe to West Coast Bias at wbwestcoastbias.substack.comEmail us at: WB.westcoastbias@gmail.comTweet us at: @WBwestcoastbiasThe BEAR Minimum - Jake and his Daughter Megan talk about student life and Cal Sports during her first year attending UC Berkeley.Subscribe to The BEAR Minimum at thebearminimum.substack.comEmail us at: wb.bearminimum@gmail.comTweet us at: @WB_BearMinimumPlease rate and review us on whatever platform you listen on.

People in the credit business are starting to see just how much AI can do for them. It can improve profits and lower defaults. It can predict demand for new services. It can see past credit scores and comprehensively assess lending risks. That's why AI's role in credit is only going to get bigger going forward. Some people are very excited about that. And some are very worried. AI will lie unless you tell it not to. It will collude on pricing with other AI. Experts say those are a couple reasons why we need to proceed with caution and better understand potential hazards.   Read an outline of the keynote speech at the 68th Economic Conference by UC-Berkeley professor Adair Morse, “AI Innovation for Credit: Frontiers of Benefits & Red Flags.” Watch a recording of the speech.

What does it take to build AI systems that are private by design—and ready for tomorrow's regulations?In this episode, I'm joined by Rishabh Poddar, CTO and Co-founder of Opaque Systems, to explore how data privacy, compliance, and AI innovation intersect in a rapidly evolving landscape. Rishabh breaks down the impact of emerging privacy laws, the risks with agentic AI systems, and why building cryptographic guarantees into the foundation of your AI stack isn't optional—it's essential.Whether you're deploying AI at scale or just experimenting, this conversation will challenge how you think about trust, governance, and the future of responsible AI.

Jessica speaks with Emily Holland, co-founder of Wild Poppy Creative Consulting, a podcast consulting company that helps small business owners hone and increase their impact on the world. She loves spending time outside rock climbing, trail running, running ultramarathons, hiking, skiing, or just watching her rescue pup Kayda frolic in the woods. Through her work on The Stokecast she told stories of how top outdoor athletes, adventurers, and entrepreneurs build their lifestyles and careers while in pursuit of adventure, purpose, and stoke. And in her podcast Nature Untold, she explored the intersection of addiction, recovery and sobriety with the outdoor community. Emily is based in Boulder, CO with her partner and pup. Follow Emily at https://www.linkedin.com/in/emilylholland/Learn more about Wild Poppy Creative Co at https://www.wildpoppycreativeco.com/ Learn more about Founded Outdoors, where Emily serves as Community Manager: https://foundedoutdoors.com/  ~Are you a high achiever, a leader, or an Ampersand looking for a sounding board? Jessica helps executives, leaders, and founders like you gain clarity and lead bravely. As your trusted advisor and growth partner, she works with you to make the invisible visible and develop an action plan to fulfill your goals. For nearly two decades, Jessica led marketing teams, launched products, and grew businesses at places like Apple, the San Francisco Opera, Smule, and Magoosh. As an Ampersand in many facets, she knows personally what it's like to hold many roles simultaneously, to sit on the executive team, and to find fulfillment. With a BA in Music and a BS in Product Design from Stanford, coupled with an MBA from UC Berkeley and coach training from the Center for Executive Coaching, her unique mix of analytical & creative allows her to bring both depth and breadth of perspective into the coaching process.As a coach, Jessica works to champion you – the full, multifaceted you – so you can thrive.Visit ⁠jessicawan.com⁠ or BOOK AN INTRO CALL: ⁠https://calendly.com/jessicawancoaching/intro-call-coaching⁠CreditsProduced and Hosted by ⁠Jessica Wan⁠Co-produced, edited, sound design, and original music by ⁠Carlos SchmittWant to support this show in a small way? Rate and review it at theampersandmanifesto.com, or buy me a coffee: ⁠coff.ee/jessicawan⁠

In today's episode of the Second in Command podcast, co-host Sivana Brewer is joined by Lauren Antonoff, COO of Life360, a leading family safety and social networking business.In this insightful conversation, Sivana and Lauren discuss the art of effective team management, focusing less on rigid reporting and more on meaningful outcomes. They explore how focusing on key results rather than micromanaging daily activities can drive better performance and foster a culture of trust. The discussion touches on how teams can prioritize what truly matters, making sure efforts align with the overall progress of the business.You'll hear about the evolving role of technology in the workplace, particularly how new tools can empower rather than replace team members. There's an emphasis on navigating change with openness and creativity, encouraging teams to see innovation as a way to amplify their strengths and take ownership of their work. Cultural values play a crucial role here, shaping how teams adapt to new challenges while staying true to their core mission.This episode invites you to rethink leadership dynamics and encourages a mindset that combines strategic focus, technological adaptability, and authentic human connection.If you've enjoyed this episode of the Second in Command podcast, be sure to leave a review and subscribe today!Enjoy!In This Episode You'll Learn:Lauren's career journey, starting at Microsoft through an acquisition, where she was 'diagnosed' as a product manager. (2:30)The challenges of integrating the Tile app into Life360 and the decision to pull resources from a standalone product launch. (6:27)Lauren's experience of hiring a CMO and CTO to help manage the marketing functions and ensure accountability. (18:37)Why focusing on a few key areas and making disciplined choices to drive success is key to Life360's future growth. (25:38)Her approach to supporting leadership, including regular meetings and in-person gatherings to develop shared views and tackle problems together. (35:22)And much more...Guest Bio:Lauren Antonoff is the Chief Operating Officer of Life360, a leading family safety and social networking app. She brings decades of experience as a product and technology leader, known for driving growth through a focus on customer value, organizational alignment, and execution. Prior to joining Life360 in 2023, Lauren held senior executive roles at GoDaddy, where she led product and services development to empower small businesses. She also spent over 18 years at Microsoft, overseeing major initiatives such as SharePoint and Office 2007, and founded the Step Up Program to advance women in leadership. A former board member of Momentive, Lauren holds a BA in Rhetoric and Political Science from UC Berkeley and began her tech career through the acquisition of ResNova Software.Resources:Connect with Lauren: Website | LinkedInConnect with Cameron: Website | LinkedInGet Cameron's latest book – "Second in...

Welcome to Art is Awesome, the show where we talk with an artist or art worker with a connection to the San Francisco Bay Area. In this Episode, Emily features an in-depth conversation with mixed media artist Demetri Broxton whose work is showcased in several prestigious museums and exhibitions in San Francisco. The discussion delves into Demetri's artistic themes, including his use of beads, the influence of his family history, and specific works like 'Save Me, Joe Lewis' and textiles depicting Black whalers for the 'Black Gold: Stories Untold' exhibit. Demetri also shares his background, how he became involved with Root Division, and answers questions about his artistic journey and influences.About Artist Demetri Broxton:Demetri Broxton is a Bay Area artist, independent curator, and the Executive Director of Root Division in San Francisco. Born and raised in Oakland, CA, he earned a BFA at UC Berkeley with an emphasis in painting and an MA in Museum Studies from San Francisco State University. His artwork has been exhibited internationally and most recently at the Chinese Historical Society of America, Art Gallery of Alberta, de Young Museum, Crocker Art Museum, Kala Art Institute, and the Norton Museum of Art. Broxton's artwork is held in several private and public collections including the Monterey Art Museum, de Young Museum, and Crocker Art Museum. He is represented by Patricia Sweetow Gallery in Los Angeles, CA.  Visit Demetri's Website:  DemetriBroxton.comFollow Demetri on Instagram:  @DBroxtonStudioFor more about the exhibit Black Gold - Stories Untold, CLICK HERE. For more about Demetri Broxton at The Guardhouse, CLICK HERE.--About Podcast Host Emily Wilson:Emily a writer in San Francisco, with work in outlets including Hyperallergic, Artforum, 48 Hills, the Daily Beast, California Magazine, Latino USA, and Women's Media Center. She often writes about the arts. For years, she taught adults getting their high school diplomas at City College of San Francisco.Follow Emily on Instagram: @PureEWilFollow Art Is Awesome on Instagram: @ArtIsAwesome_Podcast--CREDITS:Art Is Awesome is Hosted, Created & Executive Produced by Emily Wilson. Theme Music "Loopster" Courtesy of Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 4.0 LicenseThe Podcast is Co-Produced, Developed & Edited by Charlene Goto of @GoToProductions. For more info, visit Go-ToProductions.com

In this episode of The Broadband Bunch, host Brad Hine sits down with Carl Guardino, Vice President of Government Affairs and Policy at Tarana Wireless, recorded at WISPAmerica 2025 in Oklahoma City. With a career spanning decades in public policy and leadership—including 24 years as CEO of the Silicon Valley Leadership Group—Carl brings a deep understanding of how innovation, advocacy, and infrastructure intersect in the fight to bridge the digital divide. Carl shares Tarana Wireless' origin story, which was born from a graduate research project at UC Berkeley by three international students determined to solve connectivity challenges in underserved communities. Now deployed in 24 countries and nearly every U.S. state, Tarana's cutting-edge fixed wireless technology delivers high-speed, low-latency broadband—even in non-line-of-sight conditions—offering a compelling and cost-effective alternative to traditional fiber. The conversation describes the critical four “legs of the broadband table”: affordability, reliability, high speed, and low latency. Carl emphasizes the need for technology-agnostic, standards-based solutions—especially with $42.5 billion in BEAD funds at stake—and explains why real-world demonstrations and direct engagement with state officials, tribal communities, and local ISPs are essential to success.

Eric Topol (00:05):Hello, it's Eric Topol from Ground Truths, and I've got some really exciting stuff to talk to you about today. And it's about the announcement for a new Center for pediatric CRISPR Cures. And I'm delight to introduce doctors Jennifer Doudna and Priscilla Chan. And so, first let me say this is amazing to see this thing going forward. It's an outgrowth of a New England Journal paper and monumental report on CRISPR in May. [See the below post for more context]Let me introduce first, Dr. Doudna. Jennifer is the Li Ka Shing Chancellor's Chair and a Professor in the departments of chemistry and of molecular and cell biology at the University of California Berkeley. She's also the subject of this book, one of my favorite books of all time, the Code Breaker. And as you know, the 2020 Nobel Prize laureate for her work in CRISPR-Cas9 genome editing, and she founded the Innovative Genomics Institute (IGI) back 10 years ago. So Jennifer, welcome.Jennifer Doudna (01:08):Thank you, Eric. Great to be here.Eric Topol (01:10):And now Dr. Priscilla Chan, who is the co-founder of the Chan Zuckerberg Initiative (CZI) that also was started back in 2015. So here we are, a decade later, these two leaders. She is a pediatrician having trained at UCSF and is committed to the initiative which has as its mission statement, “to make it possible to cure, prevent, and manage all diseases in this century.” So today we're going to talk about a step closer to that. Welcome, Priscilla.Priscilla Chan (01:44):Thank you. Thanks for having me.Eric Topol (01:46):Alright, so I thought we'd start off by, how did you two get together? Have you known each other for over this past decade since you both got all your things going?Jennifer Doudna (01:56):Yes, we have. We've known each other for a while. And of course, I've admired the progress at the CZI on fundamental science. I was an advisor very early on and I think actually that's how we got to know each other. Right, Priscilla?Priscilla Chan (02:11):Yeah, that's right. We got to know each other then. And we've been crisscrossing paths. And I personally remember the day you won the Nobel Prize. It was in the heart of the pandemic and a lot of celebrations were happening over Zoom. And I grabbed my then 5-year-old and got onto the UCSF celebration and I was like, look, this is happening. And it was really cool for me and for my daughter.Eric Topol (02:46):Well, it's pretty remarkable convergence leading up to today's announcement, but I know Priscilla, that you've been active in this rare disease space, you've had at CZI a Rare As One Project. Maybe you could tell us a bit about that.Priscilla Chan (03:01):Yeah, so at CZI, we work on basic science research, and I think that often surprises people because they know that I'm a pediatrician. And so, they often think, oh, you must work in healthcare or healthcare delivery. And we've actually chosen very intentionally to work in basic science research. In part because my training as a pediatrician at UCSF. As you both know, UCSF is a tertiary coronary care center where we see very unusual and rare cases of pediatric presentations. And it was there where I learned how little we knew about rare diseases and diseases in general and how powerful patients were. And that research was the pipeline for hope and for new discoveries for these families that often otherwise don't have very much access to treatments or cures. They have a PDF that maybe describes what their child has. And so, I decided to invest in basic science through CZI, but always saw the power of bringing rare disease patient cohorts. One, because if you've ever met a parent of a child with rare disease, they are a force to be reckoned with. Two, they can make research so much better due to their insights as patients and patient advocates. And I think they close the distance between basic science and impact in patients. And so, we've been working on that since 2019 and has been a passion of ours.Eric Topol (04:40):Wow, that's great. Now Jennifer, this IGI that you founded a decade ago, it's doing all kinds of things that are even well beyond rare diseases. We recently spoke, I know on Ground Truths about things as diverse as editing the gut microbiome in asthma and potentially someday Alzheimer's. But here you were very much involved at IGI with the baby KJ Muldoon. Maybe you could take us through this because this is such an extraordinary advance in the whole CRISPR Cures story.Jennifer Doudna (05:18):Yes, Eric. It's a very exciting story and we're very, very proud of the teamwork that went into making it possible to cure baby KJ of his very rare disease. And in brief, the story began back in August of last year when he was born with a metabolic disorder that prevented him from digesting protein, it's called a urea cycle disorder and rare, but extremely severe. And to the point where he was in the ICU and facing a very, very difficult prognosis. And so, fortunately his clinical team at Children's Hospital of Philadelphia (CHOP) reached out to Fyodor Urnov, who is the Director of Translational Medicine at the IGI here in the Bay Area. They teamed up and realized that they could quickly diagnose that child because we had an IRB approved here at the IGI that allowed us to collect patient samples and do diagnosis. So that was done.Jennifer Doudna (06:26):We created an off-the-shelf CRISPR therapy that would be targeted to the exact mutation that caused that young boy's disease. And then we worked with the FDA in Washington to make sure that we could very safely proceed with testing of that therapy initially in the lab and then ultimately in two different animal models. And then we opened a clinical trial that allowed that boy to be enrolled with, of course his parents' approval and for him to be dosed and the result was spectacular. And in fact, he was released from the hospital recently as a happy, healthy child, gaining lots of weight and looking very chunky. So it's really exciting.Eric Topol (07:16):It's so amazing. I don't think people necessarily grasp this. This timeline [see above] that we'll post with this is just mind boggling how you could, as you said Jennifer, in about six months to go from the birth and sequencing through cell specific cultures with the genome mutations through multiple experimental models with non-human primates even, looking at off-target effects, through the multiple FDA reviews and then dosing, cumulatively three dosing to save this baby's life. It really just amazing. Now that is a template. And before we go to this new Center, I just wanted to also mention not just the timeline of compression, which is unimaginable and the partnership that you've had at IGI with I guess Danaher to help manufacture, which is just another part of the story. But also the fact that you're not just even with CRISPR 1.0 as being used in approvals previously for sickle cell and β-thalassemia, but now we're talking about base editing in vivo in the body using mRNA delivery. So maybe you could comment on that, Jennifer.Jennifer Doudna (08:38):Yeah, very good point. So yeah, we used a version of CRISPR that was created by David Liu at the Broad Institute and published and available. And so, it was possible to create that, again, targeted to the exact mutation that caused baby KJ's disease. And fortunately, there was also an off-the-shelf way to deliver it because we had access to lipid nanoparticles that were developed for other purposes including vaccinations. And the type of disease that KJ suffered from is one that is treatable by editing cells in the liver, which is where the lipid nanoparticle naturally goes. So there were definitely some serendipity here, but it was amazing how all of these pieces were available. We just had to pull them together to create this therapy.Eric Topol (09:30):Yeah, no, it is amazing. So that I think is a great substrate for starting a new Center. And so, maybe back to you Priscilla, as to what your vision was when working with Jennifer and IGI to go through with this.Priscilla Chan (09:45):I think the thing that's incredibly exciting, you mentioned that at CZI our mission is to cure, prevent, and manage all disease. And when we talked about this 10 years ago, it felt like this far off idea, but every day it seems closer and closer. And I think the part that's super exciting about this is the direct connection between the basic science that's happening in CRISPR and the molecular and down to the nucleotide understanding of these mutations and the ability to correct them. And I think many of us, our imaginations have included this possibility, but it's very exciting that it has happened with baby KJ and CHOP. And we need to be able to do the work to understand how we can treat more patients this way, how to understand the obstacles, unblock them, streamline the process, bring down the cost, so that we better understand this pathway for treatment, as well as to increasingly democratize access to this type of platform. And so, our hope is to be able to do that. Take the work and inspiration that IGI and the team at CHOP have done and continue to push forward and to look at more cases, look at more organ systems. We're going to be looking in addition to the liver, at the bone marrow and the immune system.Priscilla Chan (11:17):And to be able to really work through more of the steps so that we can bring this to more families and patients.Eric Topol (11:30):Yeah, well it's pretty remarkable because here you have incurable ultra-rare diseases. If you can help these babies, just think of what this could do in a much broader context. I mean there a lot of common diseases have their roots with some of these very rare ones. So how do you see going forward, Jennifer, as to where you UC Berkeley, Gladstone, UCSF. I'm envious of you all up there in Northern California I have to say, will pull this off. How will you get the first similar case to KJ Muldoon going forward?Jennifer Doudna (12:13):Right. Well, IGI is a joint institute, as you probably know, Eric. So we were founded 10 years ago as a joint institute between UC Berkeley and UCSF. And now we have a third campus partner, UC Davis and we have the Gladstone Institute. So we've got an extraordinary group of clinicians and researchers that are coming together for this project and the Center to make it a success. We are building a clinical team at UCSF. We have several extraordinary leaders including Jennifer Puck and Chris Dvorak, and they are both going to be involved in identifying patients that could be enrolled in this program based on their diagnosis. And we will have a clinical advisory group that will help with that as well. So we'll be vetting patients probably right after we announce this, we're going to be looking to start enrolling people who might need this type of help.Eric Topol (13:18):Do you think it's possible to go any faster right now than the six months that it took for KJ?Jennifer Doudna (13:26):I think it could be. And here's the reason. There's a very interesting possibility that because of the type of technology that we're talking about with CRISPR, which fundamentally, and you and I have talked about this previously on your other podcast. But we've talked about the fact that it's a programmable technology and that means that we can change one aspect of it, one piece of it, which is a piece of a molecule called RNA that's able to direct CRISPR to the right sequence where we want to do editing and not change anything else about it. The protein, the CRISPR protein stays the same, the delivery vehicle stays the same, everything else stays the same. And so, we're working right now with FDA to get a platform designation for CRISPR that might allow streamlining of the testing process in some cases. So it'll obviously come down to the details of the disease, but we're hopeful that in the end it will be possible. And Priscilla and I have talked about this too, that as AI continues to advance and we get more and more information about rare diseases, we'll be able to predict accurately the effects of editing. And so, in some cases in the future it may be possible to streamline the testing process even further safely.Eric Topol (14:51):And I also would note, as you both know, well this administration is really keen on genome editing and they've had a joint announcement regarding their support. And in my discussions with the FDA commissioner, this is something they are very excited about. So the timing of the new Center for pediatric CRISPR Cures is aligned with the current administration, which is good to see. It's not always the case. Now going back, Priscilla, to your point that not just for the liver because delivery has been an issue of course, and we're going to try to get after a lot of these really rare diseases, it's going to go beyond there. So this is also an exciting new dimension of the Center, as you said, to go after the bone marrow for hematopoietic cells, perhaps other organs as well.Priscilla Chan (15:42):I mean what the expertise and feasibility, the immune system is going to be the next target. Jennifer Puck has been a pioneer in this work. She's the one who designed the newborn screen that will be the tool that picks up these patients as they are born. And I think the thing that's tremendous is the immune system, first of all is active in many, many diseases, not just these cases of children born with partial or absence of immune systems. And the course right now that these babies are left with is complete isolation and then a very long and arduous course of a bone marrow transplant with high morbidity and mortality. And even if after the transplant you have complications like graft versus host and immunosuppression. And so, the idea of being able to very specifically and with less the conditioning and morbidity and mortality of the treatment, being able to address this is incredible. And the implications for other diseases like blood cancers or other hematopoietic diseases, that's incredible. And that actually has an incredibly broad base of patients that can benefit from the learnings from these babies with severe combined immunodeficiencies.Eric Topol (17:10):Yeah, I think that goes back to a point earlier maybe to amplify in that previous CRISPR generation, it required outside the body work and it was extremely laborious and time consuming and obviously added much more to the expense because of hospitalization time. This is different. This is basically doing this inside the affected patient's body. And that is one of the biggest reasons why this is a big step forward and why we're so fortunate that your Center is moving forward. Maybe before we wrap up, you might want to comment, Jennifer on how you were able to bring in to build this platform, the manufacturing arm of it, because that seems to be yet another dimension that's helpful.Jennifer Doudna (18:01):Indeed, yes. And we were again fortunate with timing because you mentioned briefly that the IGI had set up a program with the Danaher Corporation back in January of last year. We call it our Beacon project. And it's focused on rare disease. And it's a really interesting kind of a unique partnership because Danaher is a manufacturing conglomerate. So they have companies that make molecules, they make proteins, they make RNA molecules, they make delivery molecules. And so, they were excited to be involved with us because they want to be a provider of these types of therapies in the future. And they can see the future of CRISPR is very exciting. It's expanding, growing area. And so, that agreement was in place already when the baby KJ case came to our attention. And so, what we're hoping to do with Danaher is again, work with them and their scientists to continue to ask, how can we reduce the cost of these therapies by reducing the cost of the molecules that are necessary, how to make them efficiently. We already, it's very interesting, Fyodor Urnov has toured their plant in North Dakota recently, and he found in talking to their engineers, there are a number of things that we can already see will be possible to do that are going to make the process of manufacturing these molecules faster and cheaper by a lot.Eric Topol (19:28):Wow.Jennifer Doudna (19:28):So it's a win-win for everybody. And so, we're really excited to do that in the context of this new Center.Eric Topol (19:36):Oh, that's phenomenal because some of these disorders you don't have that much time to work with before they could be brain or organ or vital tissue damage. So that's great to hear that. What you built here is the significance of it can't be under emphasized, I'll say because we have this May report of baby KJ, which could have been a one-off and it could have been years before we saw another cure of an ultra-rare disorder. And what you're doing here is insurance against that. You're going to have many more cracks at this. And I think this is the excitement about having a new dedicated Center. So just in closing, maybe some remarks from you Priscilla.Priscilla Chan (20:24):I just want to emphasize one point that's really exciting as we talk about these ultra-rare cases that they're often like one in a million. All these learnings actually help maximize the impact of lots of research across the sector that impacts actually everyone's health. And so, our learnings here from these patients that have very significant presentations that really can stand to benefit from any treatment is hopefully paving the way for many, many more of us to be able to live healthier, higher quality lives through basic science.Eric Topol (21:13):And over to you, Jennifer.Jennifer Doudna (21:15):Couldn't agree more. It's a really interesting moment. I think what we hope we are, is we're at sort of an inflection point where, as I mentioned earlier, all the pieces are in place to do this kind of therapeutic and we just need a team that will focus on doing it and pulling it together. And also learning from that process so that as Priscilla just said, we are ultimately able to use the same strategy for other diseases and potentially for diseases that affect lots of people. So it's exciting.Eric Topol (21:46):For sure. Now, if I could just sum up, this is now a decade past the origination of your work of CRISPR and how already at the first decade culminated in sickle cell disease treatment and β-thalassemia. Now we're into the second decade of CRISPR. And look what we've seen, something that was unimaginable until it actually happened and was reported just a little over a month ago. Now going back to Priscilla's point, we're talking about thousands of different rare Mendelian genomic disorders, thousands of them. And if you add them all up of rare diseases, we're talking about hundreds of millions of people affected around the world. So this is a foray into something much bigger, no less the fact that some of these rare mutations are shared by common diseases and approaches. So this really big stuff, congratulations to both of you and your organizations, the Innovative Genomics Institute and the Chan Zuckerberg Initiative for taking this on. We'll be following it with very deep interest, thank you.****************************************************Thanks for listening, reading and subscribing to Ground Truths.If you found this interesting PLEASE share it!That makes the work involved in putting these together especially worthwhile.Thanks to Scripps Research, and my producer, Jessica Nguyen, and Sinjun Balabanoff for video/audio support.All content on Ground Truths—its newsletters, analyses, and podcasts, are free, open-access.Paid subscriptions are voluntary and all proceeds from them go to support Scripps Research. They do allow for posting comments and questions, which I do my best to respond to. Please don't hesitate to post comments and give me feedback. Let me know topics that you would like to see covered.Many thanks to those who have contributed—they have greatly helped fund our summer internship programs for the past two years. Get full access to Ground Truths at erictopol.substack.com/subscribe

DUMPLINS: CLICK HERE for the BEST dumplings you will EVER eat. https://www.jodisdumplins.com/Enjoy the What's Bruin Show Network!Multiple shows to entertain you on one feed:Support WBS at Patreon.com/WhatsBruinShow for just $2/month and get exclusive content and access to our SLACK channel.Twitter/X: @whatsbruinshow        Instagram: @whatsbruinshowCall the What's Bruin Network Hotline at 805-399-4WBS (Suck it Reign of Troy)We are also on YouTube HEREGet Your WBSN MERCH - Go to our MyLocker Site by Clicking HEREWhat's Bruin Show- A conversation about all things Bruin over drinks with Bruin Report Online's @mikeregaladoLA, @wbjake68 and friends!Subscribe to the What's Bruin Show at whatsbruin.substack.comEmail us at: whatsbruinshow@gmail.comTweet us at: @whatsbruinshowWest Coast Bias - LA Sports (mostly Lakers, Dodgers and NFL) with Jamaal and JakeSubscribe to West Coast Bias at wbwestcoastbias.substack.comEmail us at: WB.westcoastbias@gmail.comTweet us at: @WBwestcoastbiasThe BEAR Minimum - Jake and his Daughter Megan talk about student life and Cal Sports during her first year attending UC Berkeley.Subscribe to The BEAR Minimum at thebearminimum.substack.comEmail us at: wb.bearminimum@gmail.comTweet us at: @WB_BearMinimumPlease rate and review us on whatever platform you listen on.

00:08 — John Feffer is Director of Foreign Policy in Focus. 00:33 — Dr. John Swartzberg, clinical professor emeritus of infectious diseases at UC Berkeley's School of Public Health. The post Russia's War in Ukraine; Plus, Corona Calls appeared first on KPFA.

A conversation about the evolving world of psychedelics. While scientific breakthroughs continue to reshape our understanding of how these substances work, psychedelics are also at the center of debates about religious freedom, mystical experiences, politics, and how we treat mental health.For more than thirty years, Michael Pollan has been writing about the places where the human and natural worlds intersect: on our plates, in our farms and gardens, and in our minds. His acclaimed books include How to Change Your Mind, The Omnivore's Dilemma, and The Botany of Desire. Pollan co-founded the UC Berkeley Center for the Science of Psychedelics.Gül Dölen is professor at UC Berkeley in the Departments of Neuroscience and Psychology. Her research expertise and interests include behavioral and systems neuroscience, psychedelics, social behavior, evolution, synaptic plasticity, extracellular matrix, oxytocin and stroke, autism, PTSD, and addiction.Indre Viskontas is a cognitive neuroscientist with the University of San Francisco and a faculty member at the San Francisco Conservatory of Music. She has published groundbreaking work on the neural basis of memory and creativity, and co-hosts the podcast Inquiring Minds. Her past City Arts guests include Atul Gawande and Temple Grandin.

Twenty years ago, before the Freakonomics book tour, Bill McGowan taught Steve Levitt to speak in public. In his new book he tries to teach everyone else. SOURCES:Bill McGowan, founder and C.E.O. of Clarity Media Group. RESOURCES:Speak, Memorably: The Art of Captivating an Audience, by Bill McGowan (2025)."Sheryl Sandberg Gives UC Berkeley Commencement Keynote Speech," (UC Berkeley, 2016)."Our failing schools. Enough is enough!" by Geoffrey Canada (TED, 2013). EXTRAS:"The Power of a Bad Example – A Field Experiment In Household Garbage Disposal," by Robert Dur and Ben Vollaard (Tilburg Law and Economics Center, 2013)."Unit pricing of municipal solid waste and illegal dumping: an empirical analysis of Korean experience," by Geum-Soo Kim, Young-Jae Chang and David Kelleher (Environmental Economics and Policy Studies, 2008)."Garbage, Recycling, and Illicit Burning or Dumping," by Don Fullerton and Thomas Kinnaman (Journal of Environmental Economics and Management, 2002).

Jayme Franklin was a young college student at UC Berkeley in 2016 and chose to support Donald Trump for president. Following Trump's election, Franklin quickly became aware of a lack of conservative representation among young conservative women.     Women's magazines like Vogue and Cosmopolitan peddled leftist talking points and promoted narratives in opposition to traditional values. In response, Franklin founded The Conservateur in 2020.     The Conservateur publication provides thoughtful commentary on political and cultural issues from a conservative perspective, but also promotes classic American values through fashion. Playing on Trump “Make America Great Again Hat,” The Conservateur created its own “Make America Hot Again” hat, famously sported by Lara Trump in 2022.     Franklin joins the “Problematic Women” podcast to discuss conservative trends in America, from Trad wives to classic fashion. Also on today's show, we discuss Trump's winning policy streak, from the Big Beautiful Bill to the Alligator Alcatraz illegal alien detention facility in Florida.     Enjoy this week's show!   Learn more about your ad choices. Visit megaphone.fm/adchoices

Shreya Shankar is a  PhD student at UC Berkeley in the EECS department. This episode explores how Large Language Models (LLMs) are revolutionizing the processing of unstructured enterprise data like text documents and PDFs. It introduces DocETL, a framework using a MapReduce approach with LLMs for semantic extraction, thematic analysis, and summarization at scale.Subscribe to the Gradient Flow Newsletter

Membership | Donations | Spotify | YouTube | Apple PodcastsThis week we speak with George Pór, mentee of Doug Englebart, Founder of Future HOW, Enlivening Edge, and Campus Co-Evolve, independent scholar with past academic posts at the London School of Economics, INSEAD, UC Berkeley, California Institute of Integral Studies, and Université de Paris, wisdom-guided AI advisor at River, and consultant who has worked with clients including the UN Development Programme, HP, Greenpeace, Intel, Ford, and the World Wildlife Foundation. George has played vital roles our emerging understanding of collective intelligence, knowledge gardening, and online community. In this episode we explore his latest iteration as a Metamodern AI Shaman — what that means, why he's promoting this approach for the cultivation of hybrid human-machine wisdom, and his theory of change for a reimagined human being in an age of collaborative planet-scale intelligence.Links• Hire me for speaking or consulting• Explore the Humans On The Loop archives• Dig into nine years of mind-expanding podcasts• Browse the books we discuss on the show at Bookshop.org• Explore the interactive knowledge garden grown from over 250 episodesDiscussedExtensive context and background summary provided by George hereRadio evolve #568 - Collective Wisdom and ChatGPT with George PórPrelude to the Rise of the Compassionate AI - George PórAI and Wisdom - George PórA Future of our Interactions with AI - George PórNobel Prize in economics awarded to trio for explaining why some nations are rich and others poor (CNN)Scaling of urban income inequality in the USA - Elisa Heinrich Mora, Cate Heine, Jacob J. Jackson, Geoffrey B. West, Vicky Chuqiao Yang, and Christopher P. KempesAI Attending Human Attending AIRelationality - David JaySeeing Like A State - James C. ScottMentioned People & EpisodesLayman PascalFrederic LalouxTimothy MortonAri KushnerStephanie LeppDavid SauvageRoss DawsonStephen ReidTurquoise SoundKate RaworthMatt SegallFrancisco Varela This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit michaelgarfield.substack.com/subscribe

Smart college applicants know not to let artificial intelligence agents write their entire personal statement but might shudder at the idea of ignoring these tools entirely. How much is too much? Amy and Mike invited educator Razi Hecker to explore how much AI is just right in the college essay. What are five things you will learn in this episode? Should students avoid AI entirely when writing their college application essays? At what points in the writing process can AI be most helpful? What tasks can be AI-assisted and which ones should never be? Is there a danger that use of AI might be detected by essay readers? Why is a main thesis so critical for effective college essays? MEET OUR GUEST Razi Hecker is a Harvard graduate (Cum Laude, B.A. in Near Eastern Languages and Civilizations) and a creative writer whose work appears in literary journals, news outlets, and the most recent edition of 50 Successful Harvard Application Essays. With over 2,000 hours of college essay coaching and 10+ years in education and creative writing, Razi helps students transform personal experiences into powerful, memorable admissions narratives. His students have been accepted to every Ivy League school, as well as Stanford, MIT, and Caltech. This past year alone, over 70% of Razi's top retainer students were admitted to at least one Ivy. Those who didn't landed spots at other elite institutions such as Johns Hopkins, Carnegie Mellon, UC Berkeley, and Washington University. Find Razi at League Bound Consulting. LINKS Common App Fraud Policy Can prospective students use generative AI to help with their application to Cornell? AI Is Taking Over College Admissions RELATED EPISODES COLLEGE ESSAYS IN THE AGE OF ARTIFICIAL INTELLIGENCE MAKING YOUR COLLEGE ESSAYS COUNT WRITING RHETORICALLY IN ADMISSIONS ESSAYS ABOUT THIS PODCAST Tests and the Rest is THE college admissions industry podcast. Explore all of our episodes on the show page. ABOUT YOUR HOSTS Mike Bergin is the president of Chariot Learning and founder of TestBright, Roots2Words, and College Eagle. Amy Seeley is the president of Seeley Test Pros and LEAP. If you're interested in working with Mike and/or Amy for test preparation, training, or consulting, get in touch through our contact page.  

Decentralized finance feels like the future. This category of financial services is built on blockchain technology and transacted solely in crypto. It's executed by automated programs called “smart contracts,” which helps reduce costs. And advocates say DeFi is more democratic: Everyone involved is just an anonymous node on the blockchain, making favoritism impossible. But how will it really play out? Some tell the Boston Fed's podcast, Six Hundred Atlantic, that it requires too much tech savvy to be truly inclusive. Others worry about the safety of a “trustless system,” where the lack of an intermediary could make DeFi vulnerable to people with bad intent. And skeptics doubt decentralized finance can remain decentralized at all.   View the presentations New York University professor Hanna Halaburda and UC-Berkeley professor Christine Parlour submitted for the Boston Fed's 68th Economic Conference. Watch the panel they participated in, titled “Decentralized Finance (DeFi), Blockchain/Distributed Ledger Technology (DLT), and Smart Contracts: Hope or Hype?”

About Nagina Abdullah: Nagina Abdullah is a weight-loss coach for women in midlife and founder of the top-rated website MasalaBody.com. Nagina has a degree in Molecular and Cell Biology from UC Berkeley and earned an MBA at NYU. She has helped more than 1,500 women in midlife successfully lose weight permanently and create a lifestyle change. Nagina teaches women to boost their metabolism naturally to burn fat even when nothing else has worked. She focuses on adding and combining natural metabolism-boosting foods to reduce belly fat and get women unstuck so that they can live in their dream body.   What We Discuss In This Episode: The "Add, Don't Subtract" Method: How Eating More Helps Midlife Women Lose More Weight How to Debloat, Reduce Inflammation, & Burn Fat Naturally (Even After Menopause) How to Get Off Sugar with the 4-Part Fat-Burning Food Framework (While Still Enjoying Chocolate Cake!) How to Boost Metabolism to Lose Weight (Without Calorie Counting or Dieting) How to Boost Your Metabolism in Midlife by Adding, Timing, and Pairing Foods   Free Resource From Nagina Abdullah: Sweet Spice Cheat Sheet, which reveals the spice in your kitchen that helps curb sugar cravings and lower blood sugar—naturally. It includes: 3 powerful health benefits of this spice 5 simple ways to use it daily 1 easy recipe to get started

Hold onto your antennae and calibrate your coordinates — this episode blasts off into GNSS orbit with Mike Horton of GEODNET and Larry Fox of Bad Elf! We're talking democratization, satellites, and a robot invasion of 2025 (no big deal). From Chicago's north side to UC Berkeley and beyond, these GPS pioneers dropped knowledge like satellites in freefall: Why decentralizing GNSS might just save the world (or at least your drone survey). How GEODNET is quietly assembling the world's largest RTK network — one miner at a time. And what happens when a “Bad Elf” and a “Geo-Nerd” walk into a room. There's tech talk, trust talk, and even some good ol' fashioned Iron Man headbanging as Black Sabbath sets the musical tone for the week. Bonus: find out what woodworking, 3D printing, and Mandarin Chinese have to do with geospatial innovation. (Spoiler: nothing... and everything.) And don't miss the NLCPREP brain teaser — GPS isn't about magnets or mirrors, folks! This episode is brought to you by our friends at EMLID, TopoDOT, Hexagon, AllTerra Central, and of course, David Evans & Associates — where commitments are serious, and the relationships are even better.  

Shoshana von Blanckensee is a novelist whose debut work, Girls Girls Girls, explores coming of age, queer identity, and San Francisco in the 1990s. It follows Hannah, a young queer Jewish woman, as she embarks on a cross-country journey with her high school girlfriend - in search of acceptance and a vibrant queer community.On June 13, 2025, Shoshana von Blanckensee visited the KQED studios in San Francisco for a conversation with Poulomi Saha, an English professor and co-director of the Program in Critical Theory at UC Berkeley.

In the early 1960s, R.J. Reynolds, one of the largest and most profitable tobacco companies in the U.S. at the time, wanted to diversify its business. Its marketing strategies had been highly successful in selling its top brands, like Camel, Winston and Salem cigarettes, and executives thought, Why not apply the same strategies to, say, the food industry?So in 1963, R.J. Reynolds acquired Hawaiian Punch. It marked the beginning of the tobacco industry's entry into the food sector. In the following decades, R.J. Reynolds and Philip Morris expanded aggressively into the food industry, acquiring major brands, like Del Monte, Nabisco, General Foods, Kraft and 7UP, where they produced hyperpalatable, chemically-engineered foods now known as ultra-processed foods, or UPFs. These products were marketed especially to children and other vulnerable groups. In Berkeley Talks episode 229, Laura Schmidt, a professor of health policy in the School of Medicine at UC San Francisco, discusses how ultra-processed foods — like cookies, sodas, instant noodles, fish sticks and cereals — are a direct legacy of the tobacco industry, and are responsible for a dramatic rise in obesity, diabetes and other chronic diseases across the country. “About 60% of the calories in Americans' diets are from ultra-processed foods,” says Schmidt, who spoke at a UC Berkeley event in May. “In the mid-'80s, when we see ultra-processed foods starting to scale up in the American food supply, we also see obesity starting to really rise. That is the moment when some of the largest food companies are owned by tobacco companies.”This talk took place on May 5, 2025, and was co-sponsored by the Berkeley Food Institute (BFI) and Berkeley Public Health. It was moderated by Isabel Madzorera, an assistant professor in food, nutrition and population health at Berkeley Public Health and co-faculty director at the Berkeley Food Institute.Watch a video of the event on the Berkeley Food Institute's YouTube page.Listen to the episode and read the transcript on UC Berkeley News (news.berkeley.edu/podcasts).Music by HoliznaCC0.Photo by Cory Doctorow via Wikimedia Commons. Hosted on Acast. See acast.com/privacy for more information.

My conversation with Waj starts at 30 mins Stand Up is a daily podcast that I book,host,edit, post and promote new episodes with brilliant guests every day. Please subscribe now for as little as 5$ and gain access to a community of over 750 awesome, curious, kind, funny, brilliant, generous souls Check out StandUpwithPete.com to learn more Subscribe to Waj Substack Channel "The Left Hook" Check out his new show on youtube ‘America Unhinged,' with Francesca Fiorentini and Wajahat Ali - Zeteo's new weekly show following Trump's first 100 days in office. Wajahat Ali is a Daily Beast columnist, public speaker, recovering attorney, and tired dad of three cute kids. Get his book Go Back To Where You Came From: And, Other Helpful Recommendations on Becoming American which will be published in January 2022 by Norton. He believes in sharing stories that are by us, for everyone: universal narratives told through a culturally specific lens to entertain, educate and bridge the global divides. Listen to WAj and DAnielle Moodie on Democracy-ish  He frequently appears on television and podcasts for his brilliant, incisive, and witty political commentary. Born in the Bay Area, California to Pakistani immigrant parents, Ali went to school wearing Husky pants and knowing only three words of English. He graduated from UC Berkeley with an English major and became a licensed attorney. He knows what it feels like to be the token minority in the classroom and the darkest person in a boardroom. Like Spiderman, he's often had the power and responsibility of being the cultural ambassador of an entire group of people, those who are often marginalized, silenced, or reduced to stereotypes. His essays, interviews, and reporting have appeared in The New York Times, The Atlantic, The Washington Post, The Guardian, and New York Review of Books. Ali has spoken at many organizations, from Google to Walmart-Jet to Princeton University to the United Nations to the Chandni Indian-Pakistani Restaurant in Newark, California, and his living room in front of his three kids.  Bill Boyle is a well sourced and connected businessman who lives in Washington DC with his wife and son. Bill is a trusted friend and source for me who I met after he listened and became a regular and highly respected caller of my siriusxm radio show. Bill is a voracious reader and listeners love to hear his take. I think his analysis is as sharp as anyone you will hear on radio or TV and he has well placed friends across the federal government who are always talking to him. As far as I can tell he is not in the CIA. Follow him on twitter and park at his garages. Join us Monday's and Thursday's at 8EST for our Bi Weekly Happy Hour Hangout's !  Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on YouTube  Pete on Twitter Pete On Instagram Pete Personal FB page Stand Up with Pete FB page All things Jon Carroll  Follow and Support Pete Coe Buy Ava's Art  Hire DJ Monzyk to build your website or help you with Marketing Gift a Subscription https://www.patreon.com/PeteDominick/gift

Customer Experience as the Ultimate Global Differentiator  Shep interviews Katherine Melchior Ray, a professor at UC Berkeley, brand expert, and author. She talks about her book Brand Global, Adapt Local, and how brands can build value by understanding and personalizing experiences across different cultures and regions.  This episode of Amazing Business Radio with Shep Hyken answers the following questions and more:    How can cultural differences impact customer service interactions?  What role does personalization play in enhancing the customer experience across different cultures?  Why is it essential to understand local cultural perceptions when building brand value?  How can businesses strike a balance between global brand consistency and local cultural adaptation?  What impact does the country of origin have on storytelling for brands?  Top Takeaways:    Understanding cultural diversity builds brand value. Different countries and cities may host a variety of cultures and nationalities where diverse preferences and customer expectations coexist. By embracing these differences, businesses can tailor customer experiences to fit cultural nuances and serve diverse markets better.   Customer experience is a global differentiator. Brands can no longer rely solely on product quality or price alone. The way brands engage with and serve their customers has a significant impact on their success.   Personalization isn't just for luxury brands. Even small daily purchases, such as a cup of coffee, can be personalized to enhance customer satisfaction. Understanding customer preferences helps brands build confidence and provide a greater value than just the product itself.   Storytelling is an essential part of creating brand value because it shapes how customers perceive a brand's origins, identity, and purpose.   Understanding cultural context is important because what resonates in one region may not be as meaningful or attractive elsewhere. Brands need to strike a balance between having a consistent global message and being flexible in the experience they create to adapt to different markets' perceptions.  Trust and brand loyalty are strengthened when businesses prioritize understanding their customers' cultural backgrounds and nuances. This communicates to the customer that they are valued as individuals, not just as transactions.   Cultural dynamics evolve, so it is essential for brands to continually learn from diverse international markets and keep up with customer preferences.   Plus, Katherine shares some interesting nuances in customer interactions from countries such as Japan, Singapore, Italy, France, the United Kingdom, and more. Tune in!  Quote:   "The skills we learn to work across explicitly different cultures are the skills that we can use to embrace diversity in our own country."  About:    Katherine Melchior Ray, an educator at UC Berkeley Haas School of Business, brand expert, and co-author of Brand Global, Adapt Local: How to Build Brand Value Across Cultures. She has worked with some of the world's biggest brands, including Nike, Nordstrom, Louis Vuitton, Gucci, Hyatt, Shiseido, and Babbel.    Shep Hyken is a customer service and experience expert, New York Times bestselling author, award-winning keynote speaker, and host of Amazing Business Radio.   Learn more about your ad choices. Visit megaphone.fm/adchoices

My guest today is Ion Stoica, professor of computer science at UC Berkeley and the co-founder of Conviva, Databricks, and Anyscale. Over the last two decades, Ion's research labs - the AMP Lab, the RISE Lab, and now the Sky Computing Lab - have seeded a generation of category-defining companies. Ion has the unique ability to turn non-consensus ideas into durable businesses. He applied machine learning to video optimization with Conviva before AI became mainstream. He scaled Apache Spark into a $60B platform with Databricks. And now, with Anyscale, he's betting on Ray as the foundation for distributed AI workloads. In this episode, we dig into both sides of Ion's work: how to build world-class research labs, and how to turn research into real companies. His clarity of thought makes the future feel legible, and his track record suggests he's very often right. Hope you enjoy the conversation! Chapters: 00:00 The Spark thesis: win the ecosystem first, monetize later 01:00 Intro: From lab to company - Ion's repeatable playbook 03:00 Did you always plan to become a founder, or did it just happen? 05:23 Let's start with Spark - how did the project come about? 13:04 What were the most important early decisions at Databricks? 23:49 You were the first CEO - what did you have to learn (or unlearn)? 30:01 How was building Anyscale different from building Databricks? 33:53 What's obvious to you about the future of AI that others miss? 37:31 Why AI works so well for code 41:00 The thesis behind OPAQUE Systems 44:06 Future infra will be heterogeneous, distributed, and vertically integrated 49:03 China's edge: faster diffusion from lab to market 53:19 Platform companies still work, but only with the right investors 55:57 What role did the Databricks Unit (DBU) play in value capture? 58:02 AI progress is plateauing, but adoption is just beginning

Augustus Doricko is the founder and CEO of Rainmaker, a next generation cloud seeding company. He is a UC Berkeley dropout, Thiel Fellow, and member of the El Segundo hard tech scene.  Rainmaker uses weather resistant drones to increase precipitation and novel radar hardware to measure how much man-made precipitation is created. Rainmaker's first priority is reversing the desertification of the American west, and ultimately to terraform deserts into abundant, green, arable land. Shawn Ryan Show Sponsors: https://www.roka.com - USE CODE SRS https://www.americanfinancing.net/srs NMLS 182334, nmlsconsumeraccess.org https://www.tryarmra.com/srs https://www.betterhelp.com/srs This episode is sponsored by better help. Give online therapy a try at betterhelp.com/srs and get on your way to being your best self. https://www.shawnlikesgold.com https://www.lumen.me/srs https://www.patriotmobile.com/srs https://www.rocketmoney.com/srs https://www.shopify.com/srs https://trueclassic.com/srs Upgrade your wardrobe and save on @trueclassic at trueclassic.com/srs! #trueclassicpod Augustus Doricko Links: Rainmaker - https://www.rainmaker.com X - https://x.com/ADoricko  LinkedIn - https://www.linkedin.com/in/augustus-doricko-660b20145 Substack - https://substack.com/@doricko Learn more about your ad choices. Visit podcastchoices.com/adchoices